62863-6  PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX  

PANEL HIERARCHY

  LOINC#   LOINC Name R/O/C  Cardinality  Ex. UCUM Units 
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX    
       62865-1   PhenX - assay for chlamydia - gonorrhea protocolPhenX - assay for chlamydia - gonorrhea protocolPhenX - assay for chlamydia - gonorrhea protocol: -: Pt: ^Patient: -: PhenX    
            69865-4   Process variables for assays - gonorrhea-chlamydia PhenXProcess variables for assays - gonorrhea-chlamydia PhenXProcess variables for assays - gonorrhea-chlamydia: -: Pt: ^Patient: -: PhenX    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 66200-7   Repeatability of the assay   {ratio} 
                 66201-5   Coefficient of variation for the assay   {CV} 
            69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX    
                 66208-0   Make of the equipment used to perform...    
                 66209-8   Manufacturer of the equipment used to perform...    
       62867-7   PhenX - assay for cytokine panel 12 protocolPhenX - assay for cytokine panel 12 protocolPhenX - assay for cytokine panel 12 protocol: -: Pt: ^Patient: -: PhenX    
            69862-1   Exclusion criteria - assays PhenXExclusion criteria - assays PhenXExclusion criteria - assays: -: Pt: ^Patient: -: PhenX    
                 66177-7   Do you have hemophilia?    
                 66178-5   Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?    
            69863-9   Process variables for assays PhenXProcess variables for assays PhenXProcess variables for assays: -: Pt: ^Patient: -: PhenX    
                 66504-2   Exclusion Criteria    
                 66180-1   Was blood drawn?    
                 66181-9   Was full sample obtained?    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 66200-7   Repeatability of the assay   {ratio} 
                 66201-5   Coefficient of variation for the assay   {CV} 
            69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX    
                 66208-0   Make of the equipment used to perform...    
                 66209-8   Manufacturer of the equipment used to perform...    
       62869-3   PhenX - assay for hepatitis C protocolPhenX - assay for hepatitis C protocolPhenX - assay for hepatitis C protocol: -: Pt: ^Patient: -: PhenX    
            69862-1   Exclusion criteria - assays PhenXExclusion criteria - assays PhenXExclusion criteria - assays: -: Pt: ^Patient: -: PhenX    
                 66177-7   Do you have hemophilia?    
                 66178-5   Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?    
            69863-9   Process variables for assays PhenXProcess variables for assays PhenXProcess variables for assays: -: Pt: ^Patient: -: PhenX    
                 66504-2   Exclusion Criteria    
                 66180-1   Was blood drawn?    
                 66181-9   Was full sample obtained?    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 66200-7   Repeatability of the assay   {ratio} 
                 66201-5   Coefficient of variation for the assay   {CV} 
            69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX    
                 66208-0   Make of the equipment used to perform...    
                 66209-8   Manufacturer of the equipment used to perform...    
       62871-9   PhenX - assay for hepatitis B protocolPhenX - assay for hepatitis B protocolPhenX - assay for hepatitis B protocol: -: Pt: ^Patient: -: PhenX    
            69862-1   Exclusion criteria - assays PhenXExclusion criteria - assays PhenXExclusion criteria - assays: -: Pt: ^Patient: -: PhenX    
                 66177-7   Do you have hemophilia?    
                 66178-5   Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?    
            69863-9   Process variables for assays PhenXProcess variables for assays PhenXProcess variables for assays: -: Pt: ^Patient: -: PhenX    
                 66504-2   Exclusion Criteria    
                 66180-1   Was blood drawn?    
                 66181-9   Was full sample obtained?    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 66200-7   Repeatability of the assay   {ratio} 
                 66201-5   Coefficient of variation for the assay   {CV} 
            69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX    
                 66208-0   Make of the equipment used to perform...    
                 66209-8   Manufacturer of the equipment used to perform...    
       62873-5   PhenX - assay herpes simplex virus types 1 - 2 protocolPhenX - assay herpes simplex virus types 1 - 2 protocolPhenX - assay herpes simplex virus types 1 - 2 protocol: -: Pt: ^Patient: -: PhenX    
            69862-1   Exclusion criteria - assays PhenXExclusion criteria - assays PhenXExclusion criteria - assays: -: Pt: ^Patient: -: PhenX    
                 66177-7   Do you have hemophilia?    
                 66178-5   Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?    
            69863-9   Process variables for assays PhenXProcess variables for assays PhenXProcess variables for assays: -: Pt: ^Patient: -: PhenX    
                 66504-2   Exclusion Criteria    
                 66180-1   Was blood drawn?    
                 66181-9   Was full sample obtained?    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 66200-7   Repeatability of the assay   {ratio} 
                 66201-5   Coefficient of variation for the assay   {CV} 
            69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX    
                 66208-0   Make of the equipment used to perform...    
                 66209-8   Manufacturer of the equipment used to perform...    
       62875-0   PhenX - assay for human leukocyte antigen (HLA) genotyping protocolPhenX - assay for human leukocyte antigen (HLA) genotyping protocolPhenX - assay for human leukocyte antigen (HLA) genotyping protocol: -: Pt: ^Patient: -: PhenX    
            51953-8   Collection date of BloodCollection date of BloodCollection date: TmStp: Pt: Bld: Qn:    
            69866-2   Process variables for assays - human leukocyte antigen - HLA PhenXProcess variables for assays - human leukocyte antigen - HLA PhenXProcess variables for assays - human leukocyte antigen - HLA: -: Pt: ^Patient: -: PhenX    
                 66180-1   Was blood drawn?    
                 66181-9   Was full sample obtained?    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 66200-7   Repeatability of the assay   {ratio} 
                 66201-5   Coefficient of variation for the assay   {CV} 
            69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX    
                 66208-0   Make of the equipment used to perform...    
                 66209-8   Manufacturer of the equipment used to perform...    
       62877-6   PhenX - assay for syphilis protocolPhenX - assay for syphilis protocolPhenX - assay for syphilis protocol: -: Pt: ^Patient: -: PhenX    
            69862-1   Exclusion criteria - assays PhenXExclusion criteria - assays PhenXExclusion criteria - assays: -: Pt: ^Patient: -: PhenX    
                 66177-7   Do you have hemophilia?    
                 66178-5   Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?    
            69863-9   Process variables for assays PhenXProcess variables for assays PhenXProcess variables for assays: -: Pt: ^Patient: -: PhenX    
                 66504-2   Exclusion Criteria    
                 66180-1   Was blood drawn?    
                 66181-9   Was full sample obtained?    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 66200-7   Repeatability of the assay   {ratio} 
                 66201-5   Coefficient of variation for the assay   {CV} 
            69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX    
                 66208-0   Make of the equipment used to perform...    
                 66209-8   Manufacturer of the equipment used to perform...    
       62879-2   PhenX - conditions relevant to immune response - screener - adult protocolPhenX - conditions relevant to immune response - screener - adult protocolPhenX - conditions relevant to immune response - screener - adult protocol: -: Pt: ^Patient: -: PhenX    
            66373-2   Are you sick today?    
            66374-0   Do you have allergies to medications, food, or any vaccine?    
            66375-7   Have you ever had a serious reaction after receiving a vaccination?    
            66376-5   Do you have a long-term health problem with heart disease, lung disease, asthma, kidney disease, metabolic disease (e.g., diabetes), anemia, or other blood disorder?    
            66377-3   Do you have cancer, leukemia, AIDS, or any other immune system problem?    
            66378-1   Do you take cortisone, prednisone, other steroids, or anticancer drugs, or have you had radiation treatments?    
            66379-9   Have you had a seizure, brain, or other nervous system problem?    
            66380-7   During the past year, have you received a transfusion of blood or blood products, or have you been given immune (gamma) globulin or an antiviral drug?    
            66381-5   For women: Are you pregnant, or is there a chance you could become pregnant during the next month?    
            66382-3   Have you received any vaccinations in the past 4 weeks?    
       62880-0   PhenX - conditions relevant to immune response - screener - child protocolPhenX - conditions relevant to immune response - screener - child protocolPhenX - conditions relevant to immune response - screener - child protocol: -: Pt: ^Patient: -: PhenX    
            66383-1   Is the child sick today?    
            66384-9   Does the child have allergies to medications, food, or any vaccine?    
            66385-6   Has the child had a serious reaction to a vaccine in the past?    
            66386-4   Has the child had a seizure or a brain problem?    
            66387-2   Does the child have cancer, leukemia, AIDS, or any other immune system problem?    
            66388-0   Has the child take cortisone, prednisone, other steroids, or anticancer drugs or had x-ray treatments in the past 3 months?    
            66389-8   Has the child received a transfusion of blood or blood products or been given a medicine called immune (gamma) globulin in the past year?    
            66390-6   Is the child/teen pregnant, or is there a chance she could become pregnant during the next month?    
            66391-4   Has the child received vaccinations in the past 4 weeks?    
       62882-6   PhenX - human immunodeficiency virus (HIV) protocolPhenX - human immunodeficiency virus (HIV) protocolPhenX - human immunodeficiency virus (HIV) protocol: -: Pt: ^Patient: -: PhenX    
            69862-1   Exclusion criteria - assays PhenXExclusion criteria - assays PhenXExclusion criteria - assays: -: Pt: ^Patient: -: PhenX    
                 66177-7   Do you have hemophilia?    
                 66178-5   Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?    
            69863-9   Process variables for assays PhenXProcess variables for assays PhenXProcess variables for assays: -: Pt: ^Patient: -: PhenX    
                 66504-2   Exclusion Criteria    
                 66180-1   Was blood drawn?    
                 66181-9   Was full sample obtained?    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
                 66200-7   Repeatability of the assay   {ratio} 
                 66201-5   Coefficient of variation for the assay   {CV} 
            69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX    
                 66208-0   Make of the equipment used to perform...    
                 66209-8   Manufacturer of the equipment used to perform...    
       62884-2   PhenX - immunizations protocolPhenX - immunizations protocolPhenX - immunizations protocol: -: Pt: ^Patient: -: PhenX    
            66392-2   Booster sequence [PhenX]Booster sequence [PhenX]Booster sequence: Find: Pt: ^Patient: Nom: PhenX    
            66393-0   Booster type [PhenX]Booster type [PhenX]Booster type: Find: Pt: ^Patient: Nom: PhenX    
            66394-8   Booster 1 Age  
            66395-5   Booster 1 Date    
       62886-7   PhenX - injection drug use protocolPhenX - injection drug use protocolPhenX - injection drug use protocol: -: Pt: ^Patient: -: PhenX    
            66467-2   Have you ever, even once, used a needle to inject a drug not prescribed by a doctor?    
            66468-0   Which of the following drugs have you injected using a needle?    
            66469-8   How old were you when you first used a needle to inject any drug not prescribed by a doctor?  
            66470-6   How long ago has it been since you last used a needle to inject a drug not prescribed by a doctor?   mo 
            66472-2   During your life, altogether how many times have you injected drugs not prescribed by a doctor?   {#} 
            66473-0   Think about the period of your life when you injected drugs the most often. How often did you inject then?    
            66474-8   Have you ever been in a drug treatment or drug rehabilitation program?    
       62888-3   PhenX - international travel history protocolPhenX - international travel history protocolPhenX - international travel history protocol: -: Pt: ^Patient: -: PhenX    
            46098-0   SexSexSex: Type: Pt: ^Patient: Nom:    
            30525-0   AgeAgeAge: Time: Pt: ^Patient: Qn: R  
            46501-3   Date assessment information completed [CMS Assessment]Date assessment information completed [CMS Assessment]Date assessment information completed: Date: Pt: ^Patient: Qn: CMS Assessment   {mm/dd/yyyy} 
            21842-0   BirthplaceBirthplaceBirthplace: ID: Pt: ^Patient: Nom:    
            66475-5   Primary country of residency before age 10    
            66476-3   Country of citizenshipCountry of citizenshipCountry of citizenship: Find: Pt: ^Patient: Nom:    
            66477-1   Country of Current Residence    
            66478-9   Immigrant    
            66479-7   If you were not born in USA, indicate as closely as possible the date you first arrived here:    
            66396-3   Trip number [PhenX]Trip number [PhenX]Trip number: Find: Pt: ^Patient: Nom: PhenX    
            66397-1   Country numberCountry numberCountry number: Find: Pt: ^Patient: Nom:    
            66398-9   History of Recent Travel - Trip Start Date    
            66399-7   History of Recent Travel - Trip End Date    
            66400-3   History of Previous Travel - Country 1 - Check if travelled to country this year.    
            66401-1   History of Previous Travel - Country 1 - Check if travelled to country last year.    
            66402-9   History of Previous Travel - Country 1 - Check if travelled to country two years ago.    
            66403-7   History of Previous Travel - Country 1 - Check if travelled to country three years ago.    
            66404-5   History of Previous Travel - Country 1 - Check if travelled to country four years ago.    
            66405-2   History of Previous Travel - Country 1 - Check if travelled to country five years ago.    
            66406-0   History of Previous Travel - Country 1 - Stay was longer than 30 consecutive days this year    
            66407-8   History of Previous Travel - Country 1 - Stay was longer than 30 consecutive days last year    
            66408-6   History of Previous Travel - Country 1 - Stay was longer than 30 consecutive days two years ago    
            66409-4   History of Previous Travel - Country 1 - Stay was longer than 30 consecutive days three years ago    
            66410-2   History of Previous Travel - Country 1 - Stay was longer than 30 consecutive days four years ago    
            66411-0   History of Previous Travel - Country 1 - Stay was longer than 30 consecutive days five years ago    
            66412-8   Country of Exposure/Other    
            66413-6   Country of Exposure/Other - Country 1    
            66414-4   More Specific Place of Exposure    
            66415-1   Reason for Travel Related to Current Illness (Check One) 1..1   
            66416-9   Risk Level Qualifier (Check One) 1..1   
            66417-7   Clinical Setting (Check One) 1..1   
            66418-5   Patient Type (Check One) 1..1   
            66419-3   Did the patient have a pre-travel encounter with a health care provider? (Check One)    
            66420-1   Main Presenting Symptoms (Check at least one symptom below, but include all symptoms that apply): Abnormal Lab Test    
            66421-9   Main Presenting Symptoms (Check at least one symptom below, but include all symptoms that apply): Asymptomatic Screening    
            66422-7   Main presenting symptom [PhenX]Main presenting symptom [PhenX]Main presenting symptom: Find: Pt: ^Patient: Nom: PhenX 1..12   
            66427-6   Main Presenting Symptoms If "Other," Specify:    
            66428-4   Working diagnosis number [PhenX]Working diagnosis number [PhenX]Working diagnosis number: Find: Pt: ^Patient: Nom: PhenX    
            66429-2   Working Diagnosis 1 Status (circle one) 1..1   
            66430-0   Check this box if patient was primarily diagnosed with an infection or disease that was acquired or existed at home prior to departure or which was acquired after travel but prior to the clinic visit.    
       62890-9   PhenX - medical history protocolPhenX - medical history protocolPhenX - medical history protocol: -: Pt: ^Patient: -: PhenX    
            66480-5   Medical history [PhenX]Medical history [PhenX]Medical history: Find: Pt: ^Patient: Nom: PhenX 1..40   
            11368-8   Illness or injury onset date and timeIllness or injury onset date and timeIllness or injury onset date and time: TmStp: Pt: ^Patient: Qn:    
       62892-5   PhenX - personal - family history of autoimmune - inflammatory disorders protocolPhenX - personal - family history of autoimmune - inflammatory disorders protocolPhenX - personal - family history of autoimmune - inflammatory disorders protocol: -: Pt: ^Patient: -: PhenX    
            66434-2   Inflammatory disorder [PhenX]Inflammatory disorder [PhenX]Inflammatory disorder: Find: Pt: ^Patient: Nom: PhenX 1..7   
            66500-0   Do you have this disorder [PhenX]Do you have this disorder [PhenX]Do you have this disorder: Find: Pt: ^Patient: Nom: PhenX    
            66435-9   Family History - Disease    
            67286-5   If yes, what is his/her relationship to you?    
            54138-3   Name Family memberName Family memberName: Pn: Pt: ^Family member: Nom:    
       62894-1   PhenX - personal medical history of allergies, infectious diseases, and immunizations - child protocolPhenX - personal medical history of allergies, infectious diseases, and immunizations - child protocolPhenX - personal medical history of allergies, infectious diseases, and immunizations - child protocol: -: Pt: ^Patient: -: PhenX    
            62329-8   Birth hospital facility ID [Identifier] in FacilityBirth hospital facility ID [Identifier] in FacilityBirth hospital facility ID: ID: Pt: Facility: Nom: C 0..1   
            56092-0   Birth weight GNWCHBirth weight GNWCHBody weight^at birth: Mass: Pt: ^Patient: Qn: GNWCH   [lb_av] 
            8306-3   Body height --lyingBody height --lyingBody height^lying: Len: Pt: ^Patient: Qn:   [in_us];cm 
            22028-5   Physician [Identifier]Physician [Identifier]Physician: ID: Pt: ^Patient: Nom:    
            57073-9   Prenatal events    
            9274-2   5 minute Apgar Score5 minute Apgar ScoreScore^5M post birth: Fcn: Pt: ^Patient: Qn: Apgar 1..1  {score} 
            66436-7   Health problem sequence [PhenX]Health problem sequence [PhenX]Health problem sequence: Find: Pt: ^Patient: Nom: PhenX    
            66431-8   History of Unspecified body region disordersHistory of Unspecified body region disordersSymptoms & diseases: Hx: Pt: XXX: Nar:    
            11368-8   Illness or injury onset date and timeIllness or injury onset date and timeIllness or injury onset date and time: TmStp: Pt: ^Patient: Qn:    
            8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
            52473-6   Allergies/Causes of Reaction 0..*   
            31044-1   Patient Reaction 0..*   
            66947-3   Date Last Occurred    
            55753-8   Treatment informationTreatment informationTreatment information: Find: Pt: ^Patient: Nar:    
            66454-0   Infectious disease [PhenX]Infectious disease [PhenX]Infectious disease: Find: Pt: ^Patient: Nom: PhenX 1..10   
            30525-0   AgeAgeAge: Time: Pt: ^Patient: Qn: R  
            11368-8   Illness or injury onset date and timeIllness or injury onset date and timeIllness or injury onset date and time: TmStp: Pt: ^Patient: Qn:    
            66392-2   Booster sequence [PhenX]Booster sequence [PhenX]Booster sequence: Find: Pt: ^Patient: Nom: PhenX    
            66393-0   Booster type [PhenX]Booster type [PhenX]Booster type: Find: Pt: ^Patient: Nom: PhenX 1..12   
            66394-8   Booster 1 Age  
            66395-5   Booster 1 Date    
       62895-8   PhenX - personal medical history of allergies, infectious diseases, and immunizations - adult protocolPhenX - personal medical history of allergies, infectious diseases, and immunizations - adult protocolPhenX - personal medical history of allergies, infectious diseases, and immunizations - adult protocol: -: Pt: ^Patient: -: PhenX    
            66501-8   Noninfectious major illness [PhenX]Noninfectious major illness [PhenX]Noninfectious major illness: Find: Pt: ^Patient: Nom: PhenX    
            66432-6   Date first Dx Unspecified body regionDate first Dx Unspecified body regionDate first Dx: Date: Pt: XXX: Qn:    
            22028-5   Physician [Identifier]Physician [Identifier]Physician: ID: Pt: ^Patient: Nom:    
            67771-6   Noninfectious Major Illness 1 - Nature of Health Problems    
            54130-0   Age range at onset of disease [USSG-FHT]Age range at onset of disease [USSG-FHT]Age range at onset of disease: Type: Pt: ^Patient: Nom: USSG-FHT    
            66455-7   Noninfectious Major Illness - Condition Status    
            8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
            66456-5   Doctor visit sequence [PhenX]Doctor visit sequence [PhenX]Doctor visit sequence: Find: Pt: ^Patient: Nom: PhenX    
            52456-1   Assessment reference dateAssessment reference dateAssessment reference date: Date: Pt: ^Patient: Qn:    
            22028-5   Physician [Identifier]Physician [Identifier]Physician: ID: Pt: ^Patient: Nom:    
            29298-7   Reason for visitReason for visitReason for visit: Find: Pt: ^Patient: Nom:    
            29308-4   DiagnosisDiagnosisDiagnosis: Imp: Pt: ^Patient: Nom: 0..*   
            67772-4   Hospitalization sequence [PhenX]Hospitalization sequence [PhenX]Hospitalization sequence: Find: Pt: ^Patient: Nom: PhenX    
            66457-3   Hospitalization - Type    
            8656-1   Hospital admission dateHospital admission dateHospital admission date: TmStp: Pt: ^Patient: Qn:    
            8649-6   Hospital discharge dateHospital discharge dateHospital discharge date: TmStp: Pt: ^Patient: Qn:    
            22028-5   Physician [Identifier]Physician [Identifier]Physician: ID: Pt: ^Patient: Nom:    
            58237-9   Hospitalized at    
            46476-8   Reason for hospitalization [OASIS]Reason for hospitalization [OASIS]Reason for hospitalization: Find: Pt: ^Patient: Nom: OASIS    
            46241-6   Hospital admission diagnosis    
            55109-3   Complications O    
            66459-9   Surgery sequence [PhenX]Surgery sequence [PhenX]Surgery sequence: Find: Pt: ^Patient: Nom: PhenX    
            63968-2   Please specify date.    
            22028-5   Physician [Identifier]Physician [Identifier]Physician: ID: Pt: ^Patient: Nom:    
            58237-9   Hospitalized at    
            29306-8   Surgery procedureSurgery procedureSurgery procedure: Type: Pt: ^Patient: Nom:    
            8724-7   Surgery description    
            10215-2   Operative note findings    
            8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
            66460-7   Lab or Imaging - Instance    
            64991-3   Date of observationDate of observationDate of observation: Date: Pt: ^Patient: Qn:    
            18781-5   Ordering practitioner nameOrdering practitioner nameOrdering practitioner name: Pn: Pt: Provider: Nom: 0..*   
            67098-4   Lab or Imaging 1 - Reason    
            8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:    
            67099-2   Vendor device nameVendor device nameVendor device name: ID: Pt: {Device}: Nom:    
            66464-9   Medical Device - Device Type    
            22028-5   Physician [Identifier]Physician [Identifier]Physician: ID: Pt: ^Patient: Nom:    
            58237-9   Hospitalized at    
            64991-3   Date of observationDate of observationDate of observation: Date: Pt: ^Patient: Qn:    
            66465-6   Physical/​Occupational therapy sequence [PhenX]Physical/​Occupational therapy sequence [PhenX]Physical &or occupational therapy sequence: Find: Pt: ^Patient: Nom: PhenX    
            66466-4   Physical/Occupation Therapy - Therapy Type    
            55029-3   Physical Therapy - Therapy Start Date   {mm/dd/yyyy} 
            27673-3   Physical therapy treatment plan, End datePhysical therapy treatment plan, End dateDate.end: Date: Pt: Physical therapy treatment plan: Qn:    
            27669-1   Physical therapy treatment plan, Visit frequency TQ2Physical therapy treatment plan, Visit frequency TQ2Visit frequency: TQ2: Pt: Physical therapy treatment plan: Ord: 1..1   
            67100-8   Physical/Occupation Therapy 1 - Therapist    
 

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
PhenX domain - Infectious diseases and immunity  Pt  ^Patient  PhenX
  Long Common Name:  PhenX domain - Infectious diseases and immunity
  Shortname:  Domain - Infectious diseases immunity

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Source: PX160000

PARTS

Part Type    Part No.  Part Name   
Component   LP112420-7  PhenX domain - Infectious diseases and immunity 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  PhenX 领域 - 传染病与免疫力:-:时间点:^患者:-:PhenXPhenX 领域 - 传染病与免疫力:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  PhenX домен - Инфекционные болезни и иммунитет:-:ТчкВрм:^Пациент:-:PhenXPhenX домен - Инфекционные болезни и иммунитет:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Domain - Infectious diseases immunity PANEL.PHENX Point in time
  Pan Panl Random
  Panel Pnl  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:24 PM
  Attachment Units Required: N
  Long Common Name: PhenX domain - Infectious diseases and immunity
  Shortname: Domain - Infectious diseases immunity
  Fully Specified Name: PhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 6
  ID: 58115
  # of Panel Elements: 264
  Status (Raw): TRIAL



Selected information about each LOINC that is part of this panel



62865-1   PhenX - assay for chlamydia - gonorrhea protocolPhenX - assay for chlamydia - gonorrhea protocolPhenX - assay for chlamydia - gonorrhea protocol: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
PhenX - assay for chlamydia - gonorrhea protocol  Pt  ^Patient  PhenX
  Long Common Name:  PhenX - assay for chlamydia - gonorrhea protocol
  Shortname:  Assay for chlamydia gonorrhea proto

TERM DEFINITION/DESCRIPTION(S)
  This protocol provides basic instructions for collecting and processing urine according to National Health and Nutrition Examination Survey (NHANES) methods for assessing the presence of Chlamydia trachomatis and/or Neisseria gonorrhoeae, sexually transmitted bacterial diseases. Strand Displacement Amplification Assay is the method used.
 
 

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Source: PX160101

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP112422-3  PhenX - assay for chlamydia - gonorrhea protocol 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP20682-8  Chlamydia 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  PhenX - 衣原体检测 - 淋病方案:-:时间点:^患者:-:PhenXPhenX - 衣原体检测 - 淋病方案:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  PhenX - анализ на хламидий - гонорея протокол:-:ТчкВрм:^Пациент:-:PhenXPhenX - анализ на хламидий - гонорея протокол:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Assay for chlamydia gonorrhea proto Panel Point in time
  Chlam PANEL.PHENX Random
  Chlamid Panl  
  Pan Pnl  

CHANGE HISTORY
  Change Type: MIN

ARTICLE
  Description: Black, C. M. (1997). Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clinical Microbiology Reviews, 10(1), 160–184.
 
 
  Description: Bachmann, L. H. (2010). Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. Journal of Clinical Microbiology, 48(5):1827–1832.
 
 
  Description: Akduman, D., Ehret, J. M., Messina, K., Ragsdale, S., & Juson, F. N. (2002). Evaluation of a Strand Displacement Amplification Assay (BD ProbeTec-SDA) for detection of Neisseria gonorrhoeae in urine specimens. Journal of Clinical Microbiology, 40(1), 281–283.
 
 

CITATION
  Description: Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. (2007). National Centers for Disease Control and Prevention Laboratory Procedures Manual for Chlamydia trachomatis by BDProbeTec Analyzer. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
 
 
  Description: Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
 
 

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:24 PM
  Attachment Units Required: N
  Long Common Name: PhenX - assay for chlamydia - gonorrhea protocol
  Shortname: Assay for chlamydia gonorrhea proto
  Fully Specified Name: PhenX - assay for chlamydia - gonorrhea protocol: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 6
  ID: 58117
  Status (Raw): TRIAL


69865-4   Process variables for assays - gonorrhea-chlamydia PhenXProcess variables for assays - gonorrhea-chlamydia PhenXProcess variables for assays - gonorrhea-chlamydia: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Process variables for assays - gonorrhea-chlamydia  Pt  ^Patient  PhenX
  Long Common Name:  Process variables for assays - gonorrhea-chlamydia PhenX
  Shortname:  Process for assays-GC/Chlamydia PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145417-4  Process variables for assays - gonorrhea-chlamydia 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP20682-8  Chlamydia 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  检测的过程变量 - 淋病-衣原体:-:时间点:^患者:-:PhenX检测的过程变量 - 淋病-衣原体:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Процесс переменные для анализов - gonorrhea-chlamydia:-:ТчкВрм:^Пациент:-:PhenXПроцесс переменные для анализов - gonorrhea-chlamydia:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Chlam PANEL.PHENX Process for assays-GC/Chlamydia
  Chlamid Panl Process variables assays
  Pan Pnl Random
  Panel Point in time  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:24 PM
  Attachment Units Required: N
  Long Common Name: Process variables for assays - gonorrhea-chlamydia PhenX
  Shortname: Process for assays-GC/Chlamydia PhenX
  Fully Specified Name: Process variables for assays - gonorrhea-chlamydia: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 6
  ID: 69185
  Status (Raw): TRIAL


8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Service comment  Imp  Pt  XXX  Nom 
  Long Common Name:  Service comment
  Shortname:  Service Cmnt XXX-Imp
  DisplayName:  Service comment (Unsp spec) [Interp]

PART DEFINITION/DESCRIPTION(S)
  Part: Service comment
  Service comment terms (Service comment, Service comment 02, Service comment 03, etc.) were requested by a lab to use as an OBX lab result message for user-defined text results.
 
 

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  Common Lab Results Rank: #1514
  Common SI Lab Results Rank: #1514
  First Released in Version: 1.0h(2)
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

HL7 ATTRIBUTES
  HL7 Field ID: NTE-3

MEMBER OF THESE PANELS
  62611-9   PhenX domain - RespiratoryPhenX domain - RespiratoryPhenX domain - Respiratory: -: Pt: ^Patient: -: PhenX
  62755-4   PhenX domain - NeurologyPhenX domain - NeurologyPhenX domain - Neurology: -: Pt: ^Patient: -: PhenX
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62812-3   PhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitness: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX
  67868-0   End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728: -: Pt: ^Patient: -:
  70673-9   Functional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional assessment of chronic illness therapy - non cancer specific measures panel: -: Pt: ^Patient: -: FACIT
  74028-2   Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual medical record for clinical decision support panel: -: Pt: ^Patient: -: HL7.VMR-CDS

PARTS

Part Type    Part No.  Part Name   
Component   LP17773-0  Service comment 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP20987-1  Comment 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  服务注释:印象:时间点:XXX:名义型:服务注释:印象:时间点:XXX:名义型:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Commento di servizio 01:Imp:Pt:XXX:Nom:Commento di servizio 01:Imp:Pt:XXX:Nom:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Comentários de serviço 01:Imp:Pt:XXX:Nom:Comentários de serviço 01:Imp:Pt:XXX:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Servis önerisi:İzlnm:Zmlı:XXX:Snf:Servis önerisi:İzlnm:Zmlı:XXX:Snf:

RELATED NAMES
  cmmt Impression/interpretation of study Point in time
  cmnt Impressions Random
  Com Interp Remarks
  Comm Interpretation Service Cmnt
  Comment Misc To be specified in another part of the message
  Comments Miscellaneous Unspecified
  Commt Nominal  
  Impression Other  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:25 PM
  Long Common Name: Service comment
  Shortname: Service Cmnt XXX-Imp
  Fully Specified Name: Service comment: Imp: Pt: XXX: Nom:
     
  Component Word Count: 2
  ID: 65762
  Status (Raw): ACTIVE


8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Service comment  Imp  Pt  XXX  Nom 
  Long Common Name:  Service comment
  Shortname:  Service Cmnt XXX-Imp
  DisplayName:  Service comment (Unsp spec) [Interp]

PART DEFINITION/DESCRIPTION(S)
  Part: Service comment
  Service comment terms (Service comment, Service comment 02, Service comment 03, etc.) were requested by a lab to use as an OBX lab result message for user-defined text results.
 
 

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  Common Lab Results Rank: #1514
  Common SI Lab Results Rank: #1514
  First Released in Version: 1.0h(2)
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

HL7 ATTRIBUTES
  HL7 Field ID: NTE-3

MEMBER OF THESE PANELS
  62611-9   PhenX domain - RespiratoryPhenX domain - RespiratoryPhenX domain - Respiratory: -: Pt: ^Patient: -: PhenX
  62755-4   PhenX domain - NeurologyPhenX domain - NeurologyPhenX domain - Neurology: -: Pt: ^Patient: -: PhenX
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62812-3   PhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitness: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX
  67868-0   End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728: -: Pt: ^Patient: -:
  70673-9   Functional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional assessment of chronic illness therapy - non cancer specific measures panel: -: Pt: ^Patient: -: FACIT
  74028-2   Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual medical record for clinical decision support panel: -: Pt: ^Patient: -: HL7.VMR-CDS

PARTS

Part Type    Part No.  Part Name   
Component   LP17773-0  Service comment 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP20987-1  Comment 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  服务注释:印象:时间点:XXX:名义型:服务注释:印象:时间点:XXX:名义型:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Commento di servizio 01:Imp:Pt:XXX:Nom:Commento di servizio 01:Imp:Pt:XXX:Nom:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Comentários de serviço 01:Imp:Pt:XXX:Nom:Comentários de serviço 01:Imp:Pt:XXX:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Servis önerisi:İzlnm:Zmlı:XXX:Snf:Servis önerisi:İzlnm:Zmlı:XXX:Snf:

RELATED NAMES
  cmmt Impression/interpretation of study Point in time
  cmnt Impressions Random
  Com Interp Remarks
  Comm Interpretation Service Cmnt
  Comment Misc To be specified in another part of the message
  Comments Miscellaneous Unspecified
  Commt Nominal  
  Impression Other  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:25 PM
  Long Common Name: Service comment
  Shortname: Service Cmnt XXX-Imp
  Fully Specified Name: Service comment: Imp: Pt: XXX: Nom:
     
  Component Word Count: 2
  ID: 65762
  Status (Raw): ACTIVE


66200-7   Repeatability of the assay [Ratio] [PhenX]Repeatability of the assay [Ratio] [PhenX]Repeatability of the assay: Ratio: Pt: ^Patient: Qn: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Repeatability of the assay  Ratio  Pt  ^Patient  Qn  PhenX
  Long Common Name:  Repeatability of the assay [Ratio] [PhenX]
  Shortname:  Assay repeatability PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Repeatability of the assay
Source: PX140801120000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124998-8  Repeatability of the assay 
Property   LP6852-0  Ratio 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  此项测定的可重复性:比率:时间点:^患者:定量型:PhenX此项测定的可重复性:比率:时间点:^患者:定量型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Воспроизводимость анализа:Отношение:ТчкВрм:^Пациент:Колич:PhenXВоспроизводимость анализа:Отношение:ТчкВрм:^Пациент:Колич:PhenX

RELATED NAMES
  Assay repeatability Quan Random
  Point in time Quant Ratios
  QNT Quantitative Rto

EXAMPLE UNITS
  Unit  Source Type
  {ratio}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  {ratio} 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:25 PM
  Attachment Units Required: N
  Long Common Name: Repeatability of the assay [Ratio] [PhenX]
  Shortname: Assay repeatability PhenX
  Fully Specified Name: Repeatability of the assay: Ratio: Pt: ^Patient: Qn: PhenX
     
  Component Word Count: 4
  ID: 61804
  Status (Raw): TRIAL


66201-5   Coefficient of variation for the assay [#] [PhenX]Coefficient of variation for the assay [#] [PhenX]Coefficient of variation for the assay: Num: Pt: ^Patient: Qn: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Coefficient of variation for the assay  Num  Pt  ^Patient  Qn  PhenX
  Long Common Name:  Coefficient of variation for the assay [#] [PhenX]
  Shortname:  Coefficient of variation PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Coefficient of variation for the assay
Source: PX140801130000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124999-6  Coefficient of variation for the assay 
Property   LP6841-3  Num   [Number (count)] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  该测定的变异系数:数量(计数):时间点:^患者:定量型:PhenX该测定的变异系数:数量(计数):时间点:^患者:定量型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Коэффициент вариации анализа:Кол:ТчкВрм:^Пациент:Колич:PhenXКоэффициент вариации анализа:Кол:ТчкВрм:^Пациент:Колич:PhenX

RELATED NAMES
  Cnt Point in time Quant
  Count QNT Quantitative
  Number Quan Random

EXAMPLE UNITS
  Unit  Source Type
  {CV}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  {CV} 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:25 PM
  Attachment Units Required: N
  Long Common Name: Coefficient of variation for the assay [#] [PhenX]
  Shortname: Coefficient of variation PhenX
  Fully Specified Name: Coefficient of variation for the assay: Num: Pt: ^Patient: Qn: PhenX
     
  Component Word Count: 6
  ID: 61805
  Status (Raw): TRIAL


69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Manufacturer variables for assays  Pt  ^Patient  PhenX
  Long Common Name:  Manufacturer variables for assays PhenX
  Shortname:  Manufacturer variables assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145416-6  Manufacturer variables for assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  用于分析的制造商变量:-:时间点:^患者:-:PhenX用于分析的制造商变量:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Производитель переменные для анализов:-:ТчкВрм:^Пациент:-:PhenXПроизводитель переменные для анализов:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Manufacturer variables assays PANEL.PHENX Point in time
  Pan Panl Random
  Panel Pnl  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:26 PM
  Attachment Units Required: N
  Long Common Name: Manufacturer variables for assays PhenX
  Shortname: Manufacturer variables assays PhenX
  Fully Specified Name: Manufacturer variables for assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 4
  ID: 69184
  Status (Raw): TRIAL


66208-0   Make of the equipment used [Identifier] [PhenX]Make of the equipment used [Identifier] [PhenX]Make of the equipment used: ID: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Make of the equipment used  ID  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Make of the equipment used [Identifier] [PhenX]
  Shortname:  Make of equipment used PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Make of the equipment used to perform...
Source: PX140801110100

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP125006-9  Make of the equipment used 
Property   LP6818-1  ID   [Identifier] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  理解所使用的设备:标识符:时间点:^患者:名义型:PhenX理解所使用的设备:标识符:时间点:^患者:名义型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Модель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenXМодель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenX

RELATED NAMES
  Ident Nominal  
  Identifier Point in time  
  Make of equipment used Random  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:26 PM
  Attachment Units Required: N
  Long Common Name: Make of the equipment used [Identifier] [PhenX]
  Shortname: Make of equipment used PhenX
  Fully Specified Name: Make of the equipment used: ID: Pt: ^Patient: Nom: PhenX
     
  Component Word Count: 5
  ID: 61812
  Status (Raw): TRIAL


66209-8   Manufacturer of the equipment used [Identifier] [PhenX]Manufacturer of the equipment used [Identifier] [PhenX]Manufacturer of the equipment used: ID: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Manufacturer of the equipment used  ID  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Manufacturer of the equipment used [Identifier] [PhenX]
  Shortname:  Manufacturer of equipment used PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Manufacturer of the equipment used to perform...
Source: PX140801110200

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP125007-7  Manufacturer of the equipment used 
Property   LP6818-1  ID   [Identifier] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  所使用设备的制造商:标识符:时间点:^患者:名义型:PhenX所使用设备的制造商:标识符:时间点:^患者:名义型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Производитель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenXПроизводитель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenX

RELATED NAMES
  Ident Nominal  
  Identifier Point in time  
  Manufacturer of equipment used Random  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:26 PM
  Attachment Units Required: N
  Long Common Name: Manufacturer of the equipment used [Identifier] [PhenX]
  Shortname: Manufacturer of equipment used PhenX
  Fully Specified Name: Manufacturer of the equipment used: ID: Pt: ^Patient: Nom: PhenX
     
  Component Word Count: 5
  ID: 61814
  Status (Raw): TRIAL


62867-7   PhenX - assay for cytokine panel 12 protocolPhenX - assay for cytokine panel 12 protocolPhenX - assay for cytokine panel 12 protocol: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
PhenX - assay for cytokine panel 12 protocol  Pt  ^Patient  PhenX
  Long Common Name:  PhenX - assay for cytokine panel 12 protocol
  Shortname:  Assay for cytokine panel 12 proto

TERM DEFINITION/DESCRIPTION(S)
  This protocol provides instructions for drawing, processing, and storing blood according to the National Health and Nutrition Examination Survey (NHANES) and uses the multi-analyte fluorescent detection (MAFD) method to measure 12 different cytokines: Interferon gamma (IFN-gamma), Interleukin-1 beta (IL-1 beta), Interleukin-10 (IL-10), Interleukin-12 (IL-12), Interleukin-13 (IL-13), Interleukin-2 (IL-2), Interleukin-2 Receptor (IL-2R), Interleukin-4 (IL-4), Interleukin-5 (IL-5), Interleukin-6 (IL-6), Interleukin-8 (IL-8), Tumor Necrosis Factor alpha (TNF alpha). The Infectious Diseases and Immunity Working Group notes that although the recommendation is for the multi-analyte fluorescent detection (MAFD) method of Cytokine Panel 12 offered through ARUP Laboratories, there are additional cytokines or other immunoactive molecules that may be selected according to the individual condition(s) being studied.
 
 

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Source: PX160201

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP112424-9  PhenX - assay for cytokine panel 12 protocol 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  PhenX - 细胞因子12项组套检测方案:-:时间点:^患者:-:PhenXPhenX - 细胞因子12项组套检测方案:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  PhenX - анализ на цитокины панель 12 протокол:-:ТчкВрм:^Пациент:-:PhenXPhenX - анализ на цитокины панель 12 протокол:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Pan Pnl  
  PANEL.PHENX Point in time  
  Panl Random  

CHANGE HISTORY
  Change Type: MIN

CITATION
  Description: ARUP Laboratories, 500 Chipeta Way, Salt Lake City, UT 84108-1221, Phone: 800.242.2787, E-mail: clientservices@aruplab.com
 
 
  Description: Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
 
 

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:27 PM
  Attachment Units Required: N
  Long Common Name: PhenX - assay for cytokine panel 12 protocol
  Shortname: Assay for cytokine panel 12 proto
  Fully Specified Name: PhenX - assay for cytokine panel 12 protocol: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 7
  ID: 58119
  Status (Raw): TRIAL


69862-1   Exclusion criteria - assays PhenXExclusion criteria - assays PhenXExclusion criteria - assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Exclusion criteria - assays  Pt  ^Patient  PhenX
  Long Common Name:  Exclusion criteria - assays PhenX
  Shortname:  Exclusion criteria - assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP128623-8  Exclusion criteria - assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  排除准则 - 分析:-:时间点:^患者:-:PhenX排除准则 - 分析:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Исключения критерии - анализы:-:ТчкВрм:^Пациент:-:PhenXИсключения критерии - анализы:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Pan Panl Random
  Panel Pnl  
  PANEL.PHENX Point in time  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:27 PM
  Attachment Units Required: N
  Long Common Name: Exclusion criteria - assays PhenX
  Shortname: Exclusion criteria - assays PhenX
  Fully Specified Name: Exclusion criteria - assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 3
  ID: 69182
  Status (Raw): TRIAL


66177-7   Do you have hemophilia [PhenX]Do you have hemophilia [PhenX]Do you have hemophilia: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Do you have hemophilia  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Do you have hemophilia [PhenX]
  Shortname:  Hemophilia PhenX

TERM DEFINITION/DESCRIPTION(S)
  Exclusion from Phlebotomy
 
 

FORM CODING INSTRUCTIONS
If respondent answers Yes, they are excluded from phlebotomy

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL988-7)  
 
Source: Consensus measures for Phenotypes and Exposures
  SEQ#        Answer        Code         Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  1       LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  2       LA32-8  
  3       Refused
http://snomed.info/sct ©: 443390004 Refused (qualifier value)    
  7       LA4389-8  
  4       Don't know       9       LA12688-0  

SURVEY QUESTION
Text: Do you have hemophilia?
Source: PX140801060000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124919-4  Do you have hemophilia 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  您是否患有血友病:发现:时间点:^患者:序数型:PhenX您是否患有血友病:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  У Вас есть гемофилия:Находка:ТчкВрм:^Пациент:Пор:PhenXУ Вас есть гемофилия:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Finding Point in time Qualitative
  Findings QL Random
  Ordinal Qual Screen

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:27 PM
  Attachment Units Required: N
  Long Common Name: Do you have hemophilia [PhenX]
  Shortname: Hemophilia PhenX
  Fully Specified Name: Do you have hemophilia: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 4
  ID: 61778
  Status (Raw): TRIAL


66178-5   Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]
  Shortname:  Chemotherapy PhenX

TERM DEFINITION/DESCRIPTION(S)
  Exclusion from Phlebotomy
 
 

FORM CODING INSTRUCTIONS
If respondent answers Yes, they are excluded from phlebotomy

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL988-7)  
 
Source: Consensus measures for Phenotypes and Exposures
  SEQ#        Answer        Code         Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  1       LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  2       LA32-8  
  3       Refused
http://snomed.info/sct ©: 443390004 Refused (qualifier value)    
  7       LA4389-8  
  4       Don't know       9       LA12688-0  

SURVEY QUESTION
Text: Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
Source: PX140801070000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124920-2  Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W   [Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks] 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP200100-8  Past 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  您是否已经在过去的那4星期当中接受过癌症化学疗法,或者您是否预计在未来4星期当中会接受此类治疗:发现:时间点:^患者:序数型:PhenX您是否已经在过去的那4星期当中接受过癌症化学疗法,或者您是否预计在未来4星期当中会接受此类治疗:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Вы получали химиотерапию от рака в прошедшие 4 недели или ожидаете подобную терапию в следующие 4 недели:Находка:ТчкВрм:^Пациент:Пор:PhenXВы получали химиотерапию от рака в прошедшие 4 недели или ожидаете подобную терапию в следующие 4 недели:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Chemo Ordinal Qualitative
  Finding Point in time Random
  Findings QL Screen
  Last Qual  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:28 PM
  Attachment Units Required: N
  Long Common Name: Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]
  Shortname: Chemotherapy PhenX
  Fully Specified Name: Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 19
  ID: 61779
  Status (Raw): TRIAL


69863-9   Process variables for assays PhenXProcess variables for assays PhenXProcess variables for assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Process variables for assays  Pt  ^Patient  PhenX
  Long Common Name:  Process variables for assays PhenX
  Shortname:  Process variables assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145415-8  Process variables for assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  检测的过程变量:-:时间点:^患者:-:PhenX检测的过程变量:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Процесс переменные для анализов:-:ТчкВрм:^Пациент:-:PhenXПроцесс переменные для анализов:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Pan Panl Process variables assays
  Panel Pnl Random
  PANEL.PHENX Point in time  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:28 PM
  Attachment Units Required: N
  Long Common Name: Process variables for assays PhenX
  Shortname: Process variables assays PhenX
  Fully Specified Name: Process variables for assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 4
  ID: 69183
  Status (Raw): TRIAL


66504-2   Exclusion criteria present [PhenX]Exclusion criteria present [PhenX]Exclusion criteria present: Find: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Exclusion criteria present  Find  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Exclusion criteria present [PhenX]
  Shortname:  Exclusion criteria present PhenX

FORM CODING INSTRUCTIONS
If None, proceed with blood draw

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.38
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL1410-1)  
 
Source: Consensus measures for Phenotypes and Exposures
  SEQ#        Answer        Code         Answer ID    
  1       Hemophilia       1       LA15174-8  
  2       Received cancer chemotherapy in the last 3 weeks       2       LA15175-5  
  3       None – proceed with blood draw       3       LA15177-1  

SURVEY QUESTION
Text: Exclusion Criteria
Source: PX190301030000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145842-3  Exclusion criteria present 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  排除准则存在情况:发现:时间点:^患者:名义型:PhenX排除准则存在情况:发现:时间点:^患者:名义型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Исключения критерии присутствуют:Находка:ТчкВрм:^Пациент:Ном:PhenXИсключения критерии присутствуют:Находка:ТчкВрм:^Пациент:Ном:PhenX

RELATED NAMES
  Finding Point in time  
  Findings Random  
  Nominal    

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:28 PM
  Attachment Units Required: N
  Long Common Name: Exclusion criteria present [PhenX]
  Shortname: Exclusion criteria present PhenX
  Fully Specified Name: Exclusion criteria present: Find: Pt: ^Patient: Nom: PhenX
     
  Component Word Count: 3
  ID: 62169
  Status (Raw): TRIAL


66180-1   Was blood drawn [PhenX]Was blood drawn [PhenX]Was blood drawn: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Was blood drawn  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Was blood drawn [PhenX]
  Shortname:  Blood draw done PhenX

FORM CODING INSTRUCTIONS
If No, record reason below

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL361-7)  
 
Source: Regenstrief Institute
  SEQ#        Answer        Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  LA32-8  

SURVEY QUESTION
Text: Was blood drawn?
Source: PX140801090000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124922-8  Was blood drawn 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  是否已抽血:发现:时间点:^患者:序数型:PhenX是否已抽血:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Была ли изъята кровь:Находка:ТчкВрм:^Пациент:Пор:PhenXБыла ли изъята кровь:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Blood draw done Point in time Random
  Finding QL Screen
  Findings Qual  
  Ordinal Qualitative  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:29 PM
  Attachment Units Required: N
  Long Common Name: Was blood drawn [PhenX]
  Shortname: Blood draw done PhenX
  Fully Specified Name: Was blood drawn: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 3
  ID: 61781
  Status (Raw): TRIAL


66181-9   Was full sample obtained [PhenX]Was full sample obtained [PhenX]Was full sample obtained: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Was full sample obtained  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Was full sample obtained [PhenX]
  Shortname:  Blood draw sample PhenX

FORM CODING INSTRUCTIONS
If No, record reason below

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL361-7)  
 
Source: Regenstrief Institute
  SEQ#        Answer        Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  LA32-8  

SURVEY QUESTION
Text: Was full sample obtained?
Source: PX140801090100

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124923-6  Was full sample obtained 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  是否获得了完整的样本:发现:时间点:^患者:序数型:PhenX是否获得了完整的样本:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Был ли получен полный образец:Находка:ТчкВрм:^Пациент:Пор:PhenXБыл ли получен полный образец:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Blood draw sample Point in time Random
  Finding QL Screen
  Findings Qual  
  Ordinal Qualitative  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:29 PM
  Attachment Units Required: N
  Long Common Name: Was full sample obtained [PhenX]
  Shortname: Blood draw sample PhenX
  Fully Specified Name: Was full sample obtained: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 4
  ID: 61782
  Status (Raw): TRIAL


8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Service comment  Imp  Pt  XXX  Nom 
  Long Common Name:  Service comment
  Shortname:  Service Cmnt XXX-Imp
  DisplayName:  Service comment (Unsp spec) [Interp]

PART DEFINITION/DESCRIPTION(S)
  Part: Service comment
  Service comment terms (Service comment, Service comment 02, Service comment 03, etc.) were requested by a lab to use as an OBX lab result message for user-defined text results.
 
 

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  Common Lab Results Rank: #1514
  Common SI Lab Results Rank: #1514
  First Released in Version: 1.0h(2)
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

HL7 ATTRIBUTES
  HL7 Field ID: NTE-3

MEMBER OF THESE PANELS
  62611-9   PhenX domain - RespiratoryPhenX domain - RespiratoryPhenX domain - Respiratory: -: Pt: ^Patient: -: PhenX
  62755-4   PhenX domain - NeurologyPhenX domain - NeurologyPhenX domain - Neurology: -: Pt: ^Patient: -: PhenX
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62812-3   PhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitness: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX
  67868-0   End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728: -: Pt: ^Patient: -:
  70673-9   Functional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional assessment of chronic illness therapy - non cancer specific measures panel: -: Pt: ^Patient: -: FACIT
  74028-2   Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual medical record for clinical decision support panel: -: Pt: ^Patient: -: HL7.VMR-CDS

PARTS

Part Type    Part No.  Part Name   
Component   LP17773-0  Service comment 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP20987-1  Comment 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  服务注释:印象:时间点:XXX:名义型:服务注释:印象:时间点:XXX:名义型:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Commento di servizio 01:Imp:Pt:XXX:Nom:Commento di servizio 01:Imp:Pt:XXX:Nom:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Comentários de serviço 01:Imp:Pt:XXX:Nom:Comentários de serviço 01:Imp:Pt:XXX:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Servis önerisi:İzlnm:Zmlı:XXX:Snf:Servis önerisi:İzlnm:Zmlı:XXX:Snf:

RELATED NAMES
  cmmt Impression/interpretation of study Point in time
  cmnt Impressions Random
  Com Interp Remarks
  Comm Interpretation Service Cmnt
  Comment Misc To be specified in another part of the message
  Comments Miscellaneous Unspecified
  Commt Nominal  
  Impression Other  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:29 PM
  Long Common Name: Service comment
  Shortname: Service Cmnt XXX-Imp
  Fully Specified Name: Service comment: Imp: Pt: XXX: Nom:
     
  Component Word Count: 2
  ID: 65762
  Status (Raw): ACTIVE


8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Service comment  Imp  Pt  XXX  Nom 
  Long Common Name:  Service comment
  Shortname:  Service Cmnt XXX-Imp
  DisplayName:  Service comment (Unsp spec) [Interp]

PART DEFINITION/DESCRIPTION(S)
  Part: Service comment
  Service comment terms (Service comment, Service comment 02, Service comment 03, etc.) were requested by a lab to use as an OBX lab result message for user-defined text results.
 
 

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  Common Lab Results Rank: #1514
  Common SI Lab Results Rank: #1514
  First Released in Version: 1.0h(2)
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

HL7 ATTRIBUTES
  HL7 Field ID: NTE-3

MEMBER OF THESE PANELS
  62611-9   PhenX domain - RespiratoryPhenX domain - RespiratoryPhenX domain - Respiratory: -: Pt: ^Patient: -: PhenX
  62755-4   PhenX domain - NeurologyPhenX domain - NeurologyPhenX domain - Neurology: -: Pt: ^Patient: -: PhenX
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62812-3   PhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitness: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX
  67868-0   End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728: -: Pt: ^Patient: -:
  70673-9   Functional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional assessment of chronic illness therapy - non cancer specific measures panel: -: Pt: ^Patient: -: FACIT
  74028-2   Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual medical record for clinical decision support panel: -: Pt: ^Patient: -: HL7.VMR-CDS

PARTS

Part Type    Part No.  Part Name   
Component   LP17773-0  Service comment 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP20987-1  Comment 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  服务注释:印象:时间点:XXX:名义型:服务注释:印象:时间点:XXX:名义型:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Commento di servizio 01:Imp:Pt:XXX:Nom:Commento di servizio 01:Imp:Pt:XXX:Nom:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Comentários de serviço 01:Imp:Pt:XXX:Nom:Comentários de serviço 01:Imp:Pt:XXX:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Servis önerisi:İzlnm:Zmlı:XXX:Snf:Servis önerisi:İzlnm:Zmlı:XXX:Snf:

RELATED NAMES
  cmmt Impression/interpretation of study Point in time
  cmnt Impressions Random
  Com Interp Remarks
  Comm Interpretation Service Cmnt
  Comment Misc To be specified in another part of the message
  Comments Miscellaneous Unspecified
  Commt Nominal  
  Impression Other  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:30 PM
  Long Common Name: Service comment
  Shortname: Service Cmnt XXX-Imp
  Fully Specified Name: Service comment: Imp: Pt: XXX: Nom:
     
  Component Word Count: 2
  ID: 65762
  Status (Raw): ACTIVE


66200-7   Repeatability of the assay [Ratio] [PhenX]Repeatability of the assay [Ratio] [PhenX]Repeatability of the assay: Ratio: Pt: ^Patient: Qn: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Repeatability of the assay  Ratio  Pt  ^Patient  Qn  PhenX
  Long Common Name:  Repeatability of the assay [Ratio] [PhenX]
  Shortname:  Assay repeatability PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Repeatability of the assay
Source: PX140801120000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124998-8  Repeatability of the assay 
Property   LP6852-0  Ratio 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  此项测定的可重复性:比率:时间点:^患者:定量型:PhenX此项测定的可重复性:比率:时间点:^患者:定量型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Воспроизводимость анализа:Отношение:ТчкВрм:^Пациент:Колич:PhenXВоспроизводимость анализа:Отношение:ТчкВрм:^Пациент:Колич:PhenX

RELATED NAMES
  Assay repeatability Quan Random
  Point in time Quant Ratios
  QNT Quantitative Rto

EXAMPLE UNITS
  Unit  Source Type
  {ratio}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  {ratio} 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:30 PM
  Attachment Units Required: N
  Long Common Name: Repeatability of the assay [Ratio] [PhenX]
  Shortname: Assay repeatability PhenX
  Fully Specified Name: Repeatability of the assay: Ratio: Pt: ^Patient: Qn: PhenX
     
  Component Word Count: 4
  ID: 61804
  Status (Raw): TRIAL


66201-5   Coefficient of variation for the assay [#] [PhenX]Coefficient of variation for the assay [#] [PhenX]Coefficient of variation for the assay: Num: Pt: ^Patient: Qn: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Coefficient of variation for the assay  Num  Pt  ^Patient  Qn  PhenX
  Long Common Name:  Coefficient of variation for the assay [#] [PhenX]
  Shortname:  Coefficient of variation PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Coefficient of variation for the assay
Source: PX140801130000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124999-6  Coefficient of variation for the assay 
Property   LP6841-3  Num   [Number (count)] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  该测定的变异系数:数量(计数):时间点:^患者:定量型:PhenX该测定的变异系数:数量(计数):时间点:^患者:定量型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Коэффициент вариации анализа:Кол:ТчкВрм:^Пациент:Колич:PhenXКоэффициент вариации анализа:Кол:ТчкВрм:^Пациент:Колич:PhenX

RELATED NAMES
  Cnt Point in time Quant
  Count QNT Quantitative
  Number Quan Random

EXAMPLE UNITS
  Unit  Source Type
  {CV}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  {CV} 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:30 PM
  Attachment Units Required: N
  Long Common Name: Coefficient of variation for the assay [#] [PhenX]
  Shortname: Coefficient of variation PhenX
  Fully Specified Name: Coefficient of variation for the assay: Num: Pt: ^Patient: Qn: PhenX
     
  Component Word Count: 6
  ID: 61805
  Status (Raw): TRIAL


69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Manufacturer variables for assays  Pt  ^Patient  PhenX
  Long Common Name:  Manufacturer variables for assays PhenX
  Shortname:  Manufacturer variables assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145416-6  Manufacturer variables for assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  用于分析的制造商变量:-:时间点:^患者:-:PhenX用于分析的制造商变量:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Производитель переменные для анализов:-:ТчкВрм:^Пациент:-:PhenXПроизводитель переменные для анализов:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Manufacturer variables assays PANEL.PHENX Point in time
  Pan Panl Random
  Panel Pnl  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:30 PM
  Attachment Units Required: N
  Long Common Name: Manufacturer variables for assays PhenX
  Shortname: Manufacturer variables assays PhenX
  Fully Specified Name: Manufacturer variables for assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 4
  ID: 69184
  Status (Raw): TRIAL


66208-0   Make of the equipment used [Identifier] [PhenX]Make of the equipment used [Identifier] [PhenX]Make of the equipment used: ID: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Make of the equipment used  ID  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Make of the equipment used [Identifier] [PhenX]
  Shortname:  Make of equipment used PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Make of the equipment used to perform...
Source: PX140801110100

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP125006-9  Make of the equipment used 
Property   LP6818-1  ID   [Identifier] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  理解所使用的设备:标识符:时间点:^患者:名义型:PhenX理解所使用的设备:标识符:时间点:^患者:名义型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Модель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenXМодель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenX

RELATED NAMES
  Ident Nominal  
  Identifier Point in time  
  Make of equipment used Random  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:31 PM
  Attachment Units Required: N
  Long Common Name: Make of the equipment used [Identifier] [PhenX]
  Shortname: Make of equipment used PhenX
  Fully Specified Name: Make of the equipment used: ID: Pt: ^Patient: Nom: PhenX
     
  Component Word Count: 5
  ID: 61812
  Status (Raw): TRIAL


66209-8   Manufacturer of the equipment used [Identifier] [PhenX]Manufacturer of the equipment used [Identifier] [PhenX]Manufacturer of the equipment used: ID: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Manufacturer of the equipment used  ID  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Manufacturer of the equipment used [Identifier] [PhenX]
  Shortname:  Manufacturer of equipment used PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Manufacturer of the equipment used to perform...
Source: PX140801110200

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP125007-7  Manufacturer of the equipment used 
Property   LP6818-1  ID   [Identifier] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  所使用设备的制造商:标识符:时间点:^患者:名义型:PhenX所使用设备的制造商:标识符:时间点:^患者:名义型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Производитель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenXПроизводитель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenX

RELATED NAMES
  Ident Nominal  
  Identifier Point in time  
  Manufacturer of equipment used Random  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:31 PM
  Attachment Units Required: N
  Long Common Name: Manufacturer of the equipment used [Identifier] [PhenX]
  Shortname: Manufacturer of equipment used PhenX
  Fully Specified Name: Manufacturer of the equipment used: ID: Pt: ^Patient: Nom: PhenX
     
  Component Word Count: 5
  ID: 61814
  Status (Raw): TRIAL


62869-3   PhenX - assay for hepatitis C protocolPhenX - assay for hepatitis C protocolPhenX - assay for hepatitis C protocol: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
PhenX - assay for hepatitis C protocol  Pt  ^Patient  PhenX
  Long Common Name:  PhenX - assay for hepatitis C protocol
  Shortname:  Assay for hepatitis C proto

TERM DEFINITION/DESCRIPTION(S)
  This protocol provides instructions for drawing, processing, and storing blood for hepatitis C (HCV) from the National Health and Nutrition Examination Survey (NHANES). As multiple tests must be performed to make the most accurate diagnosis of hepatitis C, the protocol also provides basic guidelines to aid comparability among different studies. Toolkit users are referred to the U.S. Food and Drug Administration's (FDA's) approved laboratory assays.
 
 

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Source: PX160301

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP112426-4  PhenX - assay for hepatitis C protocol 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP20771-9  Hepatitis 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  PhenX - 丙型肝炎分析方案:-:时间点:^患者:-:PhenXPhenX - 丙型肝炎分析方案:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  PhenX - анализ на гепатит C протокол:-:ТчкВрм:^Пациент:-:PhenXPhenX - анализ на гепатит C протокол:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Hep Panel Point in time
  Hepatis PANEL.PHENX Random
  Hepatit Panl  
  Pan Pnl  

CHANGE HISTORY
  Change Type: MIN

CITATION
  Description: Cohen, S. (2007). Acute viral hepatitis. In R. S. Porter & J. L. Kaplan (Eds.), MERCK Manual for Healthcare Professionals. Accessed September 8, 2010, from http://www.merck.com/mmpe/sec03/ch027/ch027b.html#sec03-ch027-ch027b-434.
 
 
  Description: Alter, M. J., Kuhnert, W. L., & Finelli, L. (2003). Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Morbidity and Mortality Weekly Report, 52(RR-3), 1–16.
 
 
  Description: U.S. Food and Drug Administration. (2009). Hepatitis C. Accessed September 8, 2010, from http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm126581.htm.
 
 
  Description: Centers for Disease Control and Prevention (CDC). Division of Viral Hepatitis. Hepatitis C Information for Health Professionals. Accessed September 8, 2010 from http://www.cdc.gov/hepatitis/hcv/index.htm.
 
 
  Description: Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
 
 

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:31 PM
  Attachment Units Required: N
  Long Common Name: PhenX - assay for hepatitis C protocol
  Shortname: Assay for hepatitis C proto
  Fully Specified Name: PhenX - assay for hepatitis C protocol: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 6
  ID: 58122
  Status (Raw): TRIAL


69862-1   Exclusion criteria - assays PhenXExclusion criteria - assays PhenXExclusion criteria - assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Exclusion criteria - assays  Pt  ^Patient  PhenX
  Long Common Name:  Exclusion criteria - assays PhenX
  Shortname:  Exclusion criteria - assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP128623-8  Exclusion criteria - assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  排除准则 - 分析:-:时间点:^患者:-:PhenX排除准则 - 分析:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Исключения критерии - анализы:-:ТчкВрм:^Пациент:-:PhenXИсключения критерии - анализы:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Pan Panl Random
  Panel Pnl  
  PANEL.PHENX Point in time  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:32 PM
  Attachment Units Required: N
  Long Common Name: Exclusion criteria - assays PhenX
  Shortname: Exclusion criteria - assays PhenX
  Fully Specified Name: Exclusion criteria - assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 3
  ID: 69182
  Status (Raw): TRIAL


66177-7   Do you have hemophilia [PhenX]Do you have hemophilia [PhenX]Do you have hemophilia: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Do you have hemophilia  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Do you have hemophilia [PhenX]
  Shortname:  Hemophilia PhenX

TERM DEFINITION/DESCRIPTION(S)
  Exclusion from Phlebotomy
 
 

FORM CODING INSTRUCTIONS
If respondent answers Yes, they are excluded from phlebotomy

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL988-7)  
 
Source: Consensus measures for Phenotypes and Exposures
  SEQ#        Answer        Code         Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  1       LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  2       LA32-8  
  3       Refused
http://snomed.info/sct ©: 443390004 Refused (qualifier value)    
  7       LA4389-8  
  4       Don't know       9       LA12688-0  

SURVEY QUESTION
Text: Do you have hemophilia?
Source: PX140801060000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124919-4  Do you have hemophilia 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  您是否患有血友病:发现:时间点:^患者:序数型:PhenX您是否患有血友病:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  У Вас есть гемофилия:Находка:ТчкВрм:^Пациент:Пор:PhenXУ Вас есть гемофилия:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Finding Point in time Qualitative
  Findings QL Random
  Ordinal Qual Screen

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:32 PM
  Attachment Units Required: N
  Long Common Name: Do you have hemophilia [PhenX]
  Shortname: Hemophilia PhenX
  Fully Specified Name: Do you have hemophilia: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 4
  ID: 61778
  Status (Raw): TRIAL


66178-5   Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]
  Shortname:  Chemotherapy PhenX

TERM DEFINITION/DESCRIPTION(S)
  Exclusion from Phlebotomy
 
 

FORM CODING INSTRUCTIONS
If respondent answers Yes, they are excluded from phlebotomy

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL988-7)  
 
Source: Consensus measures for Phenotypes and Exposures
  SEQ#        Answer        Code         Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  1       LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  2       LA32-8  
  3       Refused
http://snomed.info/sct ©: 443390004 Refused (qualifier value)    
  7       LA4389-8  
  4       Don't know       9       LA12688-0  

SURVEY QUESTION
Text: Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
Source: PX140801070000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124920-2  Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W   [Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks] 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP200100-8  Past 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  您是否已经在过去的那4星期当中接受过癌症化学疗法,或者您是否预计在未来4星期当中会接受此类治疗:发现:时间点:^患者:序数型:PhenX您是否已经在过去的那4星期当中接受过癌症化学疗法,或者您是否预计在未来4星期当中会接受此类治疗:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Вы получали химиотерапию от рака в прошедшие 4 недели или ожидаете подобную терапию в следующие 4 недели:Находка:ТчкВрм:^Пациент:Пор:PhenXВы получали химиотерапию от рака в прошедшие 4 недели или ожидаете подобную терапию в следующие 4 недели:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Chemo Ordinal Qualitative
  Finding Point in time Random
  Findings QL Screen
  Last Qual  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:32 PM
  Attachment Units Required: N
  Long Common Name: Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]
  Shortname: Chemotherapy PhenX
  Fully Specified Name: Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 19
  ID: 61779
  Status (Raw): TRIAL


69863-9   Process variables for assays PhenXProcess variables for assays PhenXProcess variables for assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Process variables for assays  Pt  ^Patient  PhenX
  Long Common Name:  Process variables for assays PhenX
  Shortname:  Process variables assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145415-8  Process variables for assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  检测的过程变量:-:时间点:^患者:-:PhenX检测的过程变量:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Процесс переменные для анализов:-:ТчкВрм:^Пациент:-:PhenXПроцесс переменные для анализов:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Pan Panl Process variables assays
  Panel Pnl Random
  PANEL.PHENX Point in time  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:33 PM
  Attachment Units Required: N
  Long Common Name: Process variables for assays PhenX
  Shortname: Process variables assays PhenX
  Fully Specified Name: Process variables for assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 4
  ID: 69183
  Status (Raw): TRIAL


66504-2   Exclusion criteria present [PhenX]Exclusion criteria present [PhenX]Exclusion criteria present: Find: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Exclusion criteria present  Find  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Exclusion criteria present [PhenX]
  Shortname:  Exclusion criteria present PhenX

FORM CODING INSTRUCTIONS
If None, proceed with blood draw

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.38
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL1410-1)  
 
Source: Consensus measures for Phenotypes and Exposures
  SEQ#        Answer        Code         Answer ID    
  1       Hemophilia       1       LA15174-8  
  2       Received cancer chemotherapy in the last 3 weeks       2       LA15175-5  
  3       None – proceed with blood draw       3       LA15177-1  

SURVEY QUESTION
Text: Exclusion Criteria
Source: PX190301030000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145842-3  Exclusion criteria present 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  排除准则存在情况:发现:时间点:^患者:名义型:PhenX排除准则存在情况:发现:时间点:^患者:名义型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Исключения критерии присутствуют:Находка:ТчкВрм:^Пациент:Ном:PhenXИсключения критерии присутствуют:Находка:ТчкВрм:^Пациент:Ном:PhenX

RELATED NAMES
  Finding Point in time  
  Findings Random  
  Nominal    

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:33 PM
  Attachment Units Required: N
  Long Common Name: Exclusion criteria present [PhenX]
  Shortname: Exclusion criteria present PhenX
  Fully Specified Name: Exclusion criteria present: Find: Pt: ^Patient: Nom: PhenX
     
  Component Word Count: 3
  ID: 62169
  Status (Raw): TRIAL


66180-1   Was blood drawn [PhenX]Was blood drawn [PhenX]Was blood drawn: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Was blood drawn  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Was blood drawn [PhenX]
  Shortname:  Blood draw done PhenX

FORM CODING INSTRUCTIONS
If No, record reason below

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL361-7)  
 
Source: Regenstrief Institute
  SEQ#        Answer        Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  LA32-8  

SURVEY QUESTION
Text: Was blood drawn?
Source: PX140801090000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124922-8  Was blood drawn 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  是否已抽血:发现:时间点:^患者:序数型:PhenX是否已抽血:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Была ли изъята кровь:Находка:ТчкВрм:^Пациент:Пор:PhenXБыла ли изъята кровь:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Blood draw done Point in time Random
  Finding QL Screen
  Findings Qual  
  Ordinal Qualitative  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:33 PM
  Attachment Units Required: N
  Long Common Name: Was blood drawn [PhenX]
  Shortname: Blood draw done PhenX
  Fully Specified Name: Was blood drawn: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 3
  ID: 61781
  Status (Raw): TRIAL


66181-9   Was full sample obtained [PhenX]Was full sample obtained [PhenX]Was full sample obtained: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Was full sample obtained  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Was full sample obtained [PhenX]
  Shortname:  Blood draw sample PhenX

FORM CODING INSTRUCTIONS
If No, record reason below

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL361-7)  
 
Source: Regenstrief Institute
  SEQ#        Answer        Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  LA32-8  

SURVEY QUESTION
Text: Was full sample obtained?
Source: PX140801090100

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124923-6  Was full sample obtained 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  是否获得了完整的样本:发现:时间点:^患者:序数型:PhenX是否获得了完整的样本:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Был ли получен полный образец:Находка:ТчкВрм:^Пациент:Пор:PhenXБыл ли получен полный образец:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Blood draw sample Point in time Random
  Finding QL Screen
  Findings Qual  
  Ordinal Qualitative  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:34 PM
  Attachment Units Required: N
  Long Common Name: Was full sample obtained [PhenX]
  Shortname: Blood draw sample PhenX
  Fully Specified Name: Was full sample obtained: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 4
  ID: 61782
  Status (Raw): TRIAL


8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Service comment  Imp  Pt  XXX  Nom 
  Long Common Name:  Service comment
  Shortname:  Service Cmnt XXX-Imp
  DisplayName:  Service comment (Unsp spec) [Interp]

PART DEFINITION/DESCRIPTION(S)
  Part: Service comment
  Service comment terms (Service comment, Service comment 02, Service comment 03, etc.) were requested by a lab to use as an OBX lab result message for user-defined text results.
 
 

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  Common Lab Results Rank: #1514
  Common SI Lab Results Rank: #1514
  First Released in Version: 1.0h(2)
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

HL7 ATTRIBUTES
  HL7 Field ID: NTE-3

MEMBER OF THESE PANELS
  62611-9   PhenX domain - RespiratoryPhenX domain - RespiratoryPhenX domain - Respiratory: -: Pt: ^Patient: -: PhenX
  62755-4   PhenX domain - NeurologyPhenX domain - NeurologyPhenX domain - Neurology: -: Pt: ^Patient: -: PhenX
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62812-3   PhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitness: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX
  67868-0   End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728: -: Pt: ^Patient: -:
  70673-9   Functional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional assessment of chronic illness therapy - non cancer specific measures panel: -: Pt: ^Patient: -: FACIT
  74028-2   Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual medical record for clinical decision support panel: -: Pt: ^Patient: -: HL7.VMR-CDS

PARTS

Part Type    Part No.  Part Name   
Component   LP17773-0  Service comment 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP20987-1  Comment 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  服务注释:印象:时间点:XXX:名义型:服务注释:印象:时间点:XXX:名义型:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Commento di servizio 01:Imp:Pt:XXX:Nom:Commento di servizio 01:Imp:Pt:XXX:Nom:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Comentários de serviço 01:Imp:Pt:XXX:Nom:Comentários de serviço 01:Imp:Pt:XXX:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Servis önerisi:İzlnm:Zmlı:XXX:Snf:Servis önerisi:İzlnm:Zmlı:XXX:Snf:

RELATED NAMES
  cmmt Impression/interpretation of study Point in time
  cmnt Impressions Random
  Com Interp Remarks
  Comm Interpretation Service Cmnt
  Comment Misc To be specified in another part of the message
  Comments Miscellaneous Unspecified
  Commt Nominal  
  Impression Other  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:34 PM
  Long Common Name: Service comment
  Shortname: Service Cmnt XXX-Imp
  Fully Specified Name: Service comment: Imp: Pt: XXX: Nom:
     
  Component Word Count: 2
  ID: 65762
  Status (Raw): ACTIVE


8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Service comment  Imp  Pt  XXX  Nom 
  Long Common Name:  Service comment
  Shortname:  Service Cmnt XXX-Imp
  DisplayName:  Service comment (Unsp spec) [Interp]

PART DEFINITION/DESCRIPTION(S)
  Part: Service comment
  Service comment terms (Service comment, Service comment 02, Service comment 03, etc.) were requested by a lab to use as an OBX lab result message for user-defined text results.
 
 

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  Common Lab Results Rank: #1514
  Common SI Lab Results Rank: #1514
  First Released in Version: 1.0h(2)
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

HL7 ATTRIBUTES
  HL7 Field ID: NTE-3

MEMBER OF THESE PANELS
  62611-9   PhenX domain - RespiratoryPhenX domain - RespiratoryPhenX domain - Respiratory: -: Pt: ^Patient: -: PhenX
  62755-4   PhenX domain - NeurologyPhenX domain - NeurologyPhenX domain - Neurology: -: Pt: ^Patient: -: PhenX
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62812-3   PhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitness: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX
  67868-0   End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728: -: Pt: ^Patient: -:
  70673-9   Functional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional assessment of chronic illness therapy - non cancer specific measures panel: -: Pt: ^Patient: -: FACIT
  74028-2   Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual medical record for clinical decision support panel: -: Pt: ^Patient: -: HL7.VMR-CDS

PARTS

Part Type    Part No.  Part Name   
Component   LP17773-0  Service comment 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP20987-1  Comment 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  服务注释:印象:时间点:XXX:名义型:服务注释:印象:时间点:XXX:名义型:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Commento di servizio 01:Imp:Pt:XXX:Nom:Commento di servizio 01:Imp:Pt:XXX:Nom:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Comentários de serviço 01:Imp:Pt:XXX:Nom:Comentários de serviço 01:Imp:Pt:XXX:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Servis önerisi:İzlnm:Zmlı:XXX:Snf:Servis önerisi:İzlnm:Zmlı:XXX:Snf:

RELATED NAMES
  cmmt Impression/interpretation of study Point in time
  cmnt Impressions Random
  Com Interp Remarks
  Comm Interpretation Service Cmnt
  Comment Misc To be specified in another part of the message
  Comments Miscellaneous Unspecified
  Commt Nominal  
  Impression Other  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:34 PM
  Long Common Name: Service comment
  Shortname: Service Cmnt XXX-Imp
  Fully Specified Name: Service comment: Imp: Pt: XXX: Nom:
     
  Component Word Count: 2
  ID: 65762
  Status (Raw): ACTIVE


66200-7   Repeatability of the assay [Ratio] [PhenX]Repeatability of the assay [Ratio] [PhenX]Repeatability of the assay: Ratio: Pt: ^Patient: Qn: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Repeatability of the assay  Ratio  Pt  ^Patient  Qn  PhenX
  Long Common Name:  Repeatability of the assay [Ratio] [PhenX]
  Shortname:  Assay repeatability PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Repeatability of the assay
Source: PX140801120000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124998-8  Repeatability of the assay 
Property   LP6852-0  Ratio 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  此项测定的可重复性:比率:时间点:^患者:定量型:PhenX此项测定的可重复性:比率:时间点:^患者:定量型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Воспроизводимость анализа:Отношение:ТчкВрм:^Пациент:Колич:PhenXВоспроизводимость анализа:Отношение:ТчкВрм:^Пациент:Колич:PhenX

RELATED NAMES
  Assay repeatability Quan Random
  Point in time Quant Ratios
  QNT Quantitative Rto

EXAMPLE UNITS
  Unit  Source Type
  {ratio}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  {ratio} 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:34 PM
  Attachment Units Required: N
  Long Common Name: Repeatability of the assay [Ratio] [PhenX]
  Shortname: Assay repeatability PhenX
  Fully Specified Name: Repeatability of the assay: Ratio: Pt: ^Patient: Qn: PhenX
     
  Component Word Count: 4
  ID: 61804
  Status (Raw): TRIAL


66201-5   Coefficient of variation for the assay [#] [PhenX]Coefficient of variation for the assay [#] [PhenX]Coefficient of variation for the assay: Num: Pt: ^Patient: Qn: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Coefficient of variation for the assay  Num  Pt  ^Patient  Qn  PhenX
  Long Common Name:  Coefficient of variation for the assay [#] [PhenX]
  Shortname:  Coefficient of variation PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Coefficient of variation for the assay
Source: PX140801130000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124999-6  Coefficient of variation for the assay 
Property   LP6841-3  Num   [Number (count)] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  该测定的变异系数:数量(计数):时间点:^患者:定量型:PhenX该测定的变异系数:数量(计数):时间点:^患者:定量型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Коэффициент вариации анализа:Кол:ТчкВрм:^Пациент:Колич:PhenXКоэффициент вариации анализа:Кол:ТчкВрм:^Пациент:Колич:PhenX

RELATED NAMES
  Cnt Point in time Quant
  Count QNT Quantitative
  Number Quan Random

EXAMPLE UNITS
  Unit  Source Type
  {CV}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  {CV} 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:35 PM
  Attachment Units Required: N
  Long Common Name: Coefficient of variation for the assay [#] [PhenX]
  Shortname: Coefficient of variation PhenX
  Fully Specified Name: Coefficient of variation for the assay: Num: Pt: ^Patient: Qn: PhenX
     
  Component Word Count: 6
  ID: 61805
  Status (Raw): TRIAL


69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Manufacturer variables for assays  Pt  ^Patient  PhenX
  Long Common Name:  Manufacturer variables for assays PhenX
  Shortname:  Manufacturer variables assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145416-6  Manufacturer variables for assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  用于分析的制造商变量:-:时间点:^患者:-:PhenX用于分析的制造商变量:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Производитель переменные для анализов:-:ТчкВрм:^Пациент:-:PhenXПроизводитель переменные для анализов:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Manufacturer variables assays PANEL.PHENX Point in time
  Pan Panl Random
  Panel Pnl  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:35 PM
  Attachment Units Required: N
  Long Common Name: Manufacturer variables for assays PhenX
  Shortname: Manufacturer variables assays PhenX
  Fully Specified Name: Manufacturer variables for assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 4
  ID: 69184
  Status (Raw): TRIAL


66208-0   Make of the equipment used [Identifier] [PhenX]Make of the equipment used [Identifier] [PhenX]Make of the equipment used: ID: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Make of the equipment used  ID  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Make of the equipment used [Identifier] [PhenX]
  Shortname:  Make of equipment used PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Make of the equipment used to perform...
Source: PX140801110100

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP125006-9  Make of the equipment used 
Property   LP6818-1  ID   [Identifier] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  理解所使用的设备:标识符:时间点:^患者:名义型:PhenX理解所使用的设备:标识符:时间点:^患者:名义型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Модель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenXМодель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenX

RELATED NAMES
  Ident Nominal  
  Identifier Point in time  
  Make of equipment used Random  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:35 PM
  Attachment Units Required: N
  Long Common Name: Make of the equipment used [Identifier] [PhenX]
  Shortname: Make of equipment used PhenX
  Fully Specified Name: Make of the equipment used: ID: Pt: ^Patient: Nom: PhenX
     
  Component Word Count: 5
  ID: 61812
  Status (Raw): TRIAL


66209-8   Manufacturer of the equipment used [Identifier] [PhenX]Manufacturer of the equipment used [Identifier] [PhenX]Manufacturer of the equipment used: ID: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Manufacturer of the equipment used  ID  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Manufacturer of the equipment used [Identifier] [PhenX]
  Shortname:  Manufacturer of equipment used PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Manufacturer of the equipment used to perform...
Source: PX140801110200

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP125007-7  Manufacturer of the equipment used 
Property   LP6818-1  ID   [Identifier] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  所使用设备的制造商:标识符:时间点:^患者:名义型:PhenX所使用设备的制造商:标识符:时间点:^患者:名义型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Производитель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenXПроизводитель оборудования использованного:ID:ТчкВрм:^Пациент:Ном:PhenX

RELATED NAMES
  Ident Nominal  
  Identifier Point in time  
  Manufacturer of equipment used Random  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:36 PM
  Attachment Units Required: N
  Long Common Name: Manufacturer of the equipment used [Identifier] [PhenX]
  Shortname: Manufacturer of equipment used PhenX
  Fully Specified Name: Manufacturer of the equipment used: ID: Pt: ^Patient: Nom: PhenX
     
  Component Word Count: 5
  ID: 61814
  Status (Raw): TRIAL


62871-9   PhenX - assay for hepatitis B protocolPhenX - assay for hepatitis B protocolPhenX - assay for hepatitis B protocol: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
PhenX - assay for hepatitis B protocol  Pt  ^Patient  PhenX
  Long Common Name:  PhenX - assay for hepatitis B protocol
  Shortname:  Assay for hepatitis B proto

TERM DEFINITION/DESCRIPTION(S)
  This protocol provides instructions for drawing, processing, and storing blood for hepatitis B (HBV) from the National Health and Nutrition Examination Survey (NHANES). As multiple tests must be performed to make the most accurate diagnosis of HBV, the protocol also provides basic guidelines to aid comparability among different studies. Toolkit users are referred to the U.S. Food and Drug Administration's (FDA's) approved laboratory assays.
 
 

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Source: PX160401

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP112428-0  PhenX - assay for hepatitis B protocol 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 
Fragments for synonyms   LP20771-9  Hepatitis 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  PhenX - 乙型肝炎分析方案:-:时间点:^患者:-:PhenXPhenX - 乙型肝炎分析方案:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  PhenX - анализ на гепатит B протокол:-:ТчкВрм:^Пациент:-:PhenXPhenX - анализ на гепатит B протокол:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Hep Panel Point in time
  Hepatis PANEL.PHENX Random
  Hepatit Panl  
  Pan Pnl  

CHANGE HISTORY
  Change Type: MIN

CITATION
  Description: Weinbaum, C. M., Williams, I., Mast, E. E., Wang, S. A., Finelli, L., Wasley, A., Neitzel, S. M., & Ward, J. W.; Centers for Disease Control and Prevention. (2008). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Morbidity and Mortality Weekly Report, 57(RR-8), 1–20.
 
 
  Description: Cohen, S. (2007). Acute viral hepatitis. In R. S. Porter & J. L. Kaplan (Eds.), MERCK Manual for Healthcare Professionals. Accessed September 8, 2010, from http://www.merck.com/mmpe/sec03/ch027/ch027b.html#sec03-ch027-ch027b-434.
 
 
  Description: LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM080466.
 
 
  Description: U.S. Food and Drug Administration. Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays. (2009). Accessed September 8, 2010, from http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/
 
 
  Description: Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
 
 

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:36 PM
  Attachment Units Required: N
  Long Common Name: PhenX - assay for hepatitis B protocol
  Shortname: Assay for hepatitis B proto
  Fully Specified Name: PhenX - assay for hepatitis B protocol: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 6
  ID: 58124
  Status (Raw): TRIAL


69862-1   Exclusion criteria - assays PhenXExclusion criteria - assays PhenXExclusion criteria - assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Exclusion criteria - assays  Pt  ^Patient  PhenX
  Long Common Name:  Exclusion criteria - assays PhenX
  Shortname:  Exclusion criteria - assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP128623-8  Exclusion criteria - assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  排除准则 - 分析:-:时间点:^患者:-:PhenX排除准则 - 分析:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Исключения критерии - анализы:-:ТчкВрм:^Пациент:-:PhenXИсключения критерии - анализы:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Pan Panl Random
  Panel Pnl  
  PANEL.PHENX Point in time  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:36 PM
  Attachment Units Required: N
  Long Common Name: Exclusion criteria - assays PhenX
  Shortname: Exclusion criteria - assays PhenX
  Fully Specified Name: Exclusion criteria - assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 3
  ID: 69182
  Status (Raw): TRIAL


66177-7   Do you have hemophilia [PhenX]Do you have hemophilia [PhenX]Do you have hemophilia: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Do you have hemophilia  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Do you have hemophilia [PhenX]
  Shortname:  Hemophilia PhenX

TERM DEFINITION/DESCRIPTION(S)
  Exclusion from Phlebotomy
 
 

FORM CODING INSTRUCTIONS
If respondent answers Yes, they are excluded from phlebotomy

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL988-7)  
 
Source: Consensus measures for Phenotypes and Exposures
  SEQ#        Answer        Code         Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  1       LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  2       LA32-8  
  3       Refused
http://snomed.info/sct ©: 443390004 Refused (qualifier value)    
  7       LA4389-8  
  4       Don't know       9       LA12688-0  

SURVEY QUESTION
Text: Do you have hemophilia?
Source: PX140801060000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124919-4  Do you have hemophilia 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  您是否患有血友病:发现:时间点:^患者:序数型:PhenX您是否患有血友病:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  У Вас есть гемофилия:Находка:ТчкВрм:^Пациент:Пор:PhenXУ Вас есть гемофилия:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Finding Point in time Qualitative
  Findings QL Random
  Ordinal Qual Screen

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:37 PM
  Attachment Units Required: N
  Long Common Name: Do you have hemophilia [PhenX]
  Shortname: Hemophilia PhenX
  Fully Specified Name: Do you have hemophilia: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 4
  ID: 61778
  Status (Raw): TRIAL


66178-5   Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]
  Shortname:  Chemotherapy PhenX

TERM DEFINITION/DESCRIPTION(S)
  Exclusion from Phlebotomy
 
 

FORM CODING INSTRUCTIONS
If respondent answers Yes, they are excluded from phlebotomy

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL988-7)  
 
Source: Consensus measures for Phenotypes and Exposures
  SEQ#        Answer        Code         Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  1       LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  2       LA32-8  
  3       Refused
http://snomed.info/sct ©: 443390004 Refused (qualifier value)    
  7       LA4389-8  
  4       Don't know       9       LA12688-0  

SURVEY QUESTION
Text: Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
Source: PX140801070000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124920-2  Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W   [Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks] 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP200100-8  Past 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  您是否已经在过去的那4星期当中接受过癌症化学疗法,或者您是否预计在未来4星期当中会接受此类治疗:发现:时间点:^患者:序数型:PhenX您是否已经在过去的那4星期当中接受过癌症化学疗法,或者您是否预计在未来4星期当中会接受此类治疗:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Вы получали химиотерапию от рака в прошедшие 4 недели или ожидаете подобную терапию в следующие 4 недели:Находка:ТчкВрм:^Пациент:Пор:PhenXВы получали химиотерапию от рака в прошедшие 4 недели или ожидаете подобную терапию в следующие 4 недели:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Chemo Ordinal Qualitative
  Finding Point in time Random
  Findings QL Screen
  Last Qual  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:37 PM
  Attachment Units Required: N
  Long Common Name: Have you received cancer chemotherapy in the past 4 weeks or do you anticipate such therapy in the next 4 weeks [PhenX]
  Shortname: Chemotherapy PhenX
  Fully Specified Name: Have you received cancer chemotherapy in the past 4W or do you anticipate such therapy in the next 4W: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 19
  ID: 61779
  Status (Raw): TRIAL


69863-9   Process variables for assays PhenXProcess variables for assays PhenXProcess variables for assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Process variables for assays  Pt  ^Patient  PhenX
  Long Common Name:  Process variables for assays PhenX
  Shortname:  Process variables assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145415-8  Process variables for assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  检测的过程变量:-:时间点:^患者:-:PhenX检测的过程变量:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Процесс переменные для анализов:-:ТчкВрм:^Пациент:-:PhenXПроцесс переменные для анализов:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Pan Panl Process variables assays
  Panel Pnl Random
  PANEL.PHENX Point in time  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:37 PM
  Attachment Units Required: N
  Long Common Name: Process variables for assays PhenX
  Shortname: Process variables assays PhenX
  Fully Specified Name: Process variables for assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 4
  ID: 69183
  Status (Raw): TRIAL


66504-2   Exclusion criteria present [PhenX]Exclusion criteria present [PhenX]Exclusion criteria present: Find: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Exclusion criteria present  Find  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Exclusion criteria present [PhenX]
  Shortname:  Exclusion criteria present PhenX

FORM CODING INSTRUCTIONS
If None, proceed with blood draw

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.38
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL1410-1)  
 
Source: Consensus measures for Phenotypes and Exposures
  SEQ#        Answer        Code         Answer ID    
  1       Hemophilia       1       LA15174-8  
  2       Received cancer chemotherapy in the last 3 weeks       2       LA15175-5  
  3       None – proceed with blood draw       3       LA15177-1  

SURVEY QUESTION
Text: Exclusion Criteria
Source: PX190301030000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145842-3  Exclusion criteria present 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7750-5  Nom 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  排除准则存在情况:发现:时间点:^患者:名义型:PhenX排除准则存在情况:发现:时间点:^患者:名义型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Исключения критерии присутствуют:Находка:ТчкВрм:^Пациент:Ном:PhenXИсключения критерии присутствуют:Находка:ТчкВрм:^Пациент:Ном:PhenX

RELATED NAMES
  Finding Point in time  
  Findings Random  
  Nominal    

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:38 PM
  Attachment Units Required: N
  Long Common Name: Exclusion criteria present [PhenX]
  Shortname: Exclusion criteria present PhenX
  Fully Specified Name: Exclusion criteria present: Find: Pt: ^Patient: Nom: PhenX
     
  Component Word Count: 3
  ID: 62169
  Status (Raw): TRIAL


66180-1   Was blood drawn [PhenX]Was blood drawn [PhenX]Was blood drawn: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Was blood drawn  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Was blood drawn [PhenX]
  Shortname:  Blood draw done PhenX

FORM CODING INSTRUCTIONS
If No, record reason below

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL361-7)  
 
Source: Regenstrief Institute
  SEQ#        Answer        Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  LA32-8  

SURVEY QUESTION
Text: Was blood drawn?
Source: PX140801090000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124922-8  Was blood drawn 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  是否已抽血:发现:时间点:^患者:序数型:PhenX是否已抽血:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Была ли изъята кровь:Находка:ТчкВрм:^Пациент:Пор:PhenXБыла ли изъята кровь:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Blood draw done Point in time Random
  Finding QL Screen
  Findings Qual  
  Ordinal Qualitative  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:38 PM
  Attachment Units Required: N
  Long Common Name: Was blood drawn [PhenX]
  Shortname: Blood draw done PhenX
  Fully Specified Name: Was blood drawn: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 3
  ID: 61781
  Status (Raw): TRIAL


66181-9   Was full sample obtained [PhenX]Was full sample obtained [PhenX]Was full sample obtained: Find: Pt: ^Patient: Ord: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Was full sample obtained  Find  Pt  ^Patient  Ord  PhenX
  Long Common Name:  Was full sample obtained [PhenX]
  Shortname:  Blood draw sample PhenX

FORM CODING INSTRUCTIONS
If No, record reason below

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

NORMATIVE ANSWER LIST    (LL361-7)  
 
Source: Regenstrief Institute
  SEQ#        Answer        Answer ID    
  1       Yes
http://snomed.info/sct ©: 373066001 Yes (qualifier value)    
  LA33-6  
  2       No
http://snomed.info/sct ©: 373067005 No (qualifier value)    
  LA32-8  

SURVEY QUESTION
Text: Was full sample obtained?
Source: PX140801090100

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124923-6  Was full sample obtained 
Property   LP6813-2  Find   [Finding] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7751-3  Ord 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  是否获得了完整的样本:发现:时间点:^患者:序数型:PhenX是否获得了完整的样本:发现:时间点:^患者:序数型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Был ли получен полный образец:Находка:ТчкВрм:^Пациент:Пор:PhenXБыл ли получен полный образец:Находка:ТчкВрм:^Пациент:Пор:PhenX

RELATED NAMES
  Blood draw sample Point in time Random
  Finding QL Screen
  Findings Qual  
  Ordinal Qualitative  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:38 PM
  Attachment Units Required: N
  Long Common Name: Was full sample obtained [PhenX]
  Shortname: Blood draw sample PhenX
  Fully Specified Name: Was full sample obtained: Find: Pt: ^Patient: Ord: PhenX
     
  Component Word Count: 4
  ID: 61782
  Status (Raw): TRIAL


8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Service comment  Imp  Pt  XXX  Nom 
  Long Common Name:  Service comment
  Shortname:  Service Cmnt XXX-Imp
  DisplayName:  Service comment (Unsp spec) [Interp]

PART DEFINITION/DESCRIPTION(S)
  Part: Service comment
  Service comment terms (Service comment, Service comment 02, Service comment 03, etc.) were requested by a lab to use as an OBX lab result message for user-defined text results.
 
 

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  Common Lab Results Rank: #1514
  Common SI Lab Results Rank: #1514
  First Released in Version: 1.0h(2)
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

HL7 ATTRIBUTES
  HL7 Field ID: NTE-3

MEMBER OF THESE PANELS
  62611-9   PhenX domain - RespiratoryPhenX domain - RespiratoryPhenX domain - Respiratory: -: Pt: ^Patient: -: PhenX
  62755-4   PhenX domain - NeurologyPhenX domain - NeurologyPhenX domain - Neurology: -: Pt: ^Patient: -: PhenX
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62812-3   PhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitness: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX
  67868-0   End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728: -: Pt: ^Patient: -:
  70673-9   Functional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional assessment of chronic illness therapy - non cancer specific measures panel: -: Pt: ^Patient: -: FACIT
  74028-2   Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual medical record for clinical decision support panel: -: Pt: ^Patient: -: HL7.VMR-CDS

PARTS

Part Type    Part No.  Part Name   
Component   LP17773-0  Service comment 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP20987-1  Comment 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  服务注释:印象:时间点:XXX:名义型:服务注释:印象:时间点:XXX:名义型:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Commento di servizio 01:Imp:Pt:XXX:Nom:Commento di servizio 01:Imp:Pt:XXX:Nom:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Comentários de serviço 01:Imp:Pt:XXX:Nom:Comentários de serviço 01:Imp:Pt:XXX:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Servis önerisi:İzlnm:Zmlı:XXX:Snf:Servis önerisi:İzlnm:Zmlı:XXX:Snf:

RELATED NAMES
  cmmt Impression/interpretation of study Point in time
  cmnt Impressions Random
  Com Interp Remarks
  Comm Interpretation Service Cmnt
  Comment Misc To be specified in another part of the message
  Comments Miscellaneous Unspecified
  Commt Nominal  
  Impression Other  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:38 PM
  Long Common Name: Service comment
  Shortname: Service Cmnt XXX-Imp
  Fully Specified Name: Service comment: Imp: Pt: XXX: Nom:
     
  Component Word Count: 2
  ID: 65762
  Status (Raw): ACTIVE


8251-1   Service commentService commentService comment: Imp: Pt: XXX: Nom:  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Service comment  Imp  Pt  XXX  Nom 
  Long Common Name:  Service comment
  Shortname:  Service Cmnt XXX-Imp
  DisplayName:  Service comment (Unsp spec) [Interp]

PART DEFINITION/DESCRIPTION(S)
  Part: Service comment
  Service comment terms (Service comment, Service comment 02, Service comment 03, etc.) were requested by a lab to use as an OBX lab result message for user-defined text results.
 
 

BASIC ATTRIBUTES
  Class/Type: MISC/Lab
  Common Lab Results Rank: #1514
  Common SI Lab Results Rank: #1514
  First Released in Version: 1.0h(2)
  Last Updated in Version: 2.38
  Order vs. Obs.: Observation
  Status: Active

HL7 ATTRIBUTES
  HL7 Field ID: NTE-3

MEMBER OF THESE PANELS
  62611-9   PhenX domain - RespiratoryPhenX domain - RespiratoryPhenX domain - Respiratory: -: Pt: ^Patient: -: PhenX
  62755-4   PhenX domain - NeurologyPhenX domain - NeurologyPhenX domain - Neurology: -: Pt: ^Patient: -: PhenX
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62812-3   PhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitnessPhenX domain - Physical activity and physical fitness: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX
  67868-0   End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End Stage Renal Disease (ESRD) Medical Evidence Report, Medicare Entitlement AndOr Patient Registration - OMB CMS form 2728End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728: -: Pt: ^Patient: -:
  70673-9   Functional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional Assessment of Chronic Illness Therapy (FACIT) - Non cancer Specific Measures PanelFunctional assessment of chronic illness therapy - non cancer specific measures panel: -: Pt: ^Patient: -: FACIT
  74028-2   Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual Medical Record for Clinical Decision Support panel HL7.VMR-CDSVirtual medical record for clinical decision support panel: -: Pt: ^Patient: -: HL7.VMR-CDS

PARTS

Part Type    Part No.  Part Name   
Component   LP17773-0  Service comment 
Property   LP6819-9  Imp   [Impression/interpretation of study] 
Time   LP6960-1  Pt   [Point in time (spot)] 
System   LP7735-6  XXX 
Scale   LP7750-5  Nom 
Fragments for synonyms   LP20987-1  Comment 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  服务注释:印象:时间点:XXX:名义型:服务注释:印象:时间点:XXX:名义型:
  Italian (ITALY)  (From: Regenstrief-generated full translation based on part translation provided by Consiglio Nazionale delle Ricerche)
 
  Commento di servizio 01:Imp:Pt:XXX:Nom:Commento di servizio 01:Imp:Pt:XXX:Nom:
  Portuguese (BRAZIL)  (From: HL7 Brazil Institute)
 
  Comentários de serviço 01:Imp:Pt:XXX:Nom:Comentários de serviço 01:Imp:Pt:XXX:Nom:
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:Служебный комментарий:Впчт:ТчкВрм:XXX:Ном:
  Spanish (ARGENTINA)  (From: Conceptum Medical Terminology Center)
 
  comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:comentario del servicio, 01:impresión/​interpretación del estudio:punto en el tiempo:XXX:Nominal:
  Spanish (SPAIN)  (From: Regenstrief-generated full translation based on part translation provided by the Clinical Laboratory Committee of SERVICIO EXTREMEÑO DE SALUD, with the support of BITAC MAP.)
 
  Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:Comentario del servicio 01:Impresión/​interpretación del estudio:Punto temporal:XXX:Nom:
  Turkish (TURKEY)  (From: Regenstrief-generated full translation based on part translation provided by LOINC Turkish Translation Group and the Turkish Ministry of Health)
 
  Servis önerisi:İzlnm:Zmlı:XXX:Snf:Servis önerisi:İzlnm:Zmlı:XXX:Snf:

RELATED NAMES
  cmmt Impression/interpretation of study Point in time
  cmnt Impressions Random
  Com Interp Remarks
  Comm Interpretation Service Cmnt
  Comment Misc To be specified in another part of the message
  Comments Miscellaneous Unspecified
  Commt Nominal  
  Impression Other  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:39 PM
  Long Common Name: Service comment
  Shortname: Service Cmnt XXX-Imp
  Fully Specified Name: Service comment: Imp: Pt: XXX: Nom:
     
  Component Word Count: 2
  ID: 65762
  Status (Raw): ACTIVE


66200-7   Repeatability of the assay [Ratio] [PhenX]Repeatability of the assay [Ratio] [PhenX]Repeatability of the assay: Ratio: Pt: ^Patient: Qn: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Repeatability of the assay  Ratio  Pt  ^Patient  Qn  PhenX
  Long Common Name:  Repeatability of the assay [Ratio] [PhenX]
  Shortname:  Assay repeatability PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Repeatability of the assay
Source: PX140801120000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124998-8  Repeatability of the assay 
Property   LP6852-0  Ratio 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  此项测定的可重复性:比率:时间点:^患者:定量型:PhenX此项测定的可重复性:比率:时间点:^患者:定量型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Воспроизводимость анализа:Отношение:ТчкВрм:^Пациент:Колич:PhenXВоспроизводимость анализа:Отношение:ТчкВрм:^Пациент:Колич:PhenX

RELATED NAMES
  Assay repeatability Quan Random
  Point in time Quant Ratios
  QNT Quantitative Rto

EXAMPLE UNITS
  Unit  Source Type
  {ratio}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  {ratio} 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:39 PM
  Attachment Units Required: N
  Long Common Name: Repeatability of the assay [Ratio] [PhenX]
  Shortname: Assay repeatability PhenX
  Fully Specified Name: Repeatability of the assay: Ratio: Pt: ^Patient: Qn: PhenX
     
  Component Word Count: 4
  ID: 61804
  Status (Raw): TRIAL


66201-5   Coefficient of variation for the assay [#] [PhenX]Coefficient of variation for the assay [#] [PhenX]Coefficient of variation for the assay: Num: Pt: ^Patient: Qn: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Coefficient of variation for the assay  Num  Pt  ^Patient  Qn  PhenX
  Long Common Name:  Coefficient of variation for the assay [#] [PhenX]
  Shortname:  Coefficient of variation PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

SURVEY QUESTION
Text: Coefficient of variation for the assay
Source: PX140801130000

MEMBER OF THESE PANELS
  62787-7   PhenX domain - DiabetesPhenX domain - DiabetesPhenX domain - Diabetes: -: Pt: ^Patient: -: PhenX
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX
  62896-6   PhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and jointPhenX domain - Skin, bone, muscle and joint: -: Pt: ^Patient: -: PhenX
  62949-3   PhenX domain - GastrointestinalPhenX domain - GastrointestinalPhenX domain - Gastrointestinal: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP124999-6  Coefficient of variation for the assay 
Property   LP6841-3  Num   [Number (count)] 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7753-9  Qn 
Method   LP95333-8  PhenX 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  该测定的变异系数:数量(计数):时间点:^患者:定量型:PhenX该测定的变异系数:数量(计数):时间点:^患者:定量型:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Коэффициент вариации анализа:Кол:ТчкВрм:^Пациент:Колич:PhenXКоэффициент вариации анализа:Кол:ТчкВрм:^Пациент:Колич:PhenX

RELATED NAMES
  Cnt Point in time Quant
  Count QNT Quantitative
  Number Quan Random

EXAMPLE UNITS
  Unit  Source Type
  {CV}  EXAMPLE UCUM UNITS 

UNITS (INTERNAL DETAILS)
  Source Type:  EXAMPLE UCUM UNITS 
  Unit:  {CV} 

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:39 PM
  Attachment Units Required: N
  Long Common Name: Coefficient of variation for the assay [#] [PhenX]
  Shortname: Coefficient of variation PhenX
  Fully Specified Name: Coefficient of variation for the assay: Num: Pt: ^Patient: Qn: PhenX
     
  Component Word Count: 6
  ID: 61805
  Status (Raw): TRIAL


69864-7   Manufacturer variables for assays PhenXManufacturer variables for assays PhenXManufacturer variables for assays: -: Pt: ^Patient: -: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Manufacturer variables for assays  Pt  ^Patient  PhenX
  Long Common Name:  Manufacturer variables for assays PhenX
  Shortname:  Manufacturer variables assays PhenX

BASIC ATTRIBUTES
  Class/Type: PANEL.PHENX/Clinical
  Panel Type: Panel
  First Released in Version: 2.40
  Last Updated in Version: 2.40
  Status: Trial – caution, may change

MEMBER OF THESE PANELS
  62863-6   PhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunityPhenX domain - Infectious diseases and immunity: -: Pt: ^Patient: -: PhenX

PARTS

Part Type    Part No.  Part Name   
Component   LP145416-6  Manufacturer variables for assays 
Property   LP6769-6 
Time   LP6960-1  Pt   [Point in time (spot)] 
Super System   LP6985-8  Patient 
Scale   LP7747-1 
Method   LP95333-8  PhenX 
Fragments for synonyms   LP21059-8  Panel 

LANGUAGE VARIANTS
  Chinese (CHINA)  (From: Regenstrief-generated full translation based on part translation provided by Lin Zhang, A LOINC volunteer from China)
 
  用于分析的制造商变量:-:时间点:^患者:-:PhenX用于分析的制造商变量:-:时间点:^患者:-:PhenX
  Russian (RUSSIAN FEDERATION)  (From: Regenstrief-generated full translation based on part translation provided by Yaroslavl State Medical Academy)
 
  Производитель переменные для анализов:-:ТчкВрм:^Пациент:-:PhenXПроизводитель переменные для анализов:-:ТчкВрм:^Пациент:-:PhenX

RELATED NAMES
  Manufacturer variables assays PANEL.PHENX Point in time
  Pan Panl Random
  Panel Pnl  

CHANGE HISTORY
  Change Type: MIN

INTERNAL FIELDS
  Detail Page Created On: 12/12/2018 11:30:40 PM
  Attachment Units Required: N
  Long Common Name: Manufacturer variables for assays PhenX
  Shortname: Manufacturer variables assays PhenX
  Fully Specified Name: Manufacturer variables for assays: -: Pt: ^Patient: -: PhenX
     
  Component Word Count: 4
  ID: 69184
  Status (Raw): TRIAL


66208-0   Make of the equipment used [Identifier] [PhenX]Make of the equipment used [Identifier] [PhenX]Make of the equipment used: ID: Pt: ^Patient: Nom: PhenX  

NAME
  Fully-Specified Name: 
Component   Property   Time   System   Scale   Method
Make of the equipment used  ID  Pt  ^Patient  Nom  PhenX
  Long Common Name:  Make of the equipment used [Identifier] [PhenX]
  Shortname:  Make of equipment used PhenX

BASIC ATTRIBUTES
  Class/Type: PHENX/Clinical
  First Released in Version: 2.36
  Last Updated in Version: 2.65
  Status: Trial – caution, may change.
Change Reason: Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.